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                                INTRODUCTION 
 
Siddha system of Medicine is unique and is Perpetuating for centuries 
because of its merits. Siddhars had abundant knowledge in various branches 
of medicine and utilized herbs, metals, minerals and any organic material, 
available in the universe as medicine  
 
 According to Siddha concept, Disease is caused when the normal 
equilibrium of 3 humours (Vatham, pitham and kabam) is disturbed. The 
factors which affect this equilibrium are environment, climatic conditions, 
diet and physical activities. “Kuzhanthai Maruthuvam” is one among the 
glorious branches of Siddha system inside which is hidden an enormous 
treasure for a healthy society. 
 
 Here “Suzhi kanam” is specifically taken for the Dissertation subject 
as it probably correlates with childhood Asthma, which is a respiratory 
disease encountered by a large population of children today and limits their 
daily activities. 
 
 The Trial drug “Kanai Kirutham” is chosen on the  basis of classical 
attributes of respective ingredients according to the doctrine of suvai (taste), 
Gunam (property), Pirivu (metabolic changes after digestion), virium 
(Potency) and seygai (specific action which would pacify the vitiated humors 
in suzhi kanam). 
 
 Therefore I expect this Lipid based nutritive medicine to be 
Immunoboosting, safe and efficient in reducing the symptoms of Suzhi 
kanam and bring quick recovery.  
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AIM AND OBJECTIVES 
Aim: 
 
 The principal aim of the present study of Suzhi kanam with clinical 
study is to evaluate the efficacy of the trial Drug “Kanai kirutham” in the 
treatment of Suzhi kanam without any side effects. 
 
      To ensure a new approach in the diagnosis and treatment of disease.  
 
Objectives: 
  
 The Main objective of the present study is to create awareness about 
the Siddha system and to highlight the efficacy of Siddha drugs among 
the public. 
 To Explore the Etiology, clinical Features, diagnosis and investigations 
of Suzhikanam through various Siddha literature. 
 To know the extent of correlation of Etiopathogenesis, signs and 
symptoms of Suzhi kanam with Kanai kirutham. 
 To analyze the Biochemical, Pharmacological, Antimicrobial action of 
the trial drug and its therapeutic phytoconstituents. 
 To educate the patients and their Parents in terms of prevention of 
disease, Diet, habits and the importance of Pranayama and yogasanas. 
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REVIEW OF LITERATURE 
Siddha aspect: 
fzk;: 
  rpj;j kUj;JtKiwapy; Foe;ijfspd; Neha; fzpg;gpy; fzk; 
my;yJ fiz vd;gJ Kf;fpakhdjhFk;. 
 
,ay; : 
  “fzk;” vd;gJ  “fh;g;gr;R+L”  vdf; $Wth;. khe;jj;jpd; njhlh; 
NehNa fzkhFk;. ,J Fotpf;F khe;j Neha; Vw;gl;L KOtJk; 
Fzkhfhky; clypy; ,Ue;Nj Kw;wptUk;. 
 
“fhpKfdbia tho;j;jpf; fkythrdpiag; Nghw;wp 
 mhpa nre;jkpopdhNy afj;jpa Kdptd; nrhd;d 
nghpa khtpahjpahd NgRkf; fizapd; Nwh\k; 
 njhpaNt Gtpapd; kPJ nrg;GNtd; rpe;ij itj;Nj.” 
 
    - guuhrNrfuk; ghyNuhf epjhdk; 
 
fzk; - nghUs; tpsf;fk; 
 
T.V.rhk;grptk; gps;is mfuhjp> jkpo;nkhop mfuhjp> fk;gh; - jkpo; 
mfuhjp Nghd;w E}y;fspy; “fzk;” vd;w thh;j;ijf;Fg; gpd;tUk; 
nghUs; $wg;gl;Ls;sJ: 
“xU Neha;”> “FiwT”> “$l;lk;”> “jpul;rp 
NkYk; “fiz” vd;gjid  “mk;G” vdTk; nghUs; nfhs;syhk;. 
Nghh;f;fsj;jpy; mk;gpidj; njhLf;Fk;NghJ khh;igf; Fwpitj;Nj 
nrYj;JtJ Nghy; fiz NehapYk; Kjd;ikahf ghjpf;fg;gLk; 
clypd; gFjp khh;G vd;gjhy; ,e;Neha;f;F ,g;ngah; 
mike;jpUf;fyhk;. 
 12 
 
vdNt fzk; vd;gjid jpul;rpahd gy FwpFzq;fs; nfhz;l 
khh;gpid Kjd;ikahf ghjpf;Fk; Neha;epiy vd mwpayhk;. 
 
Neha; tUk; top 
                      fzk; 
 
 
 
 
 
 
fh;g;gr; R+L Vw;gLk; tpjk; 
 
“gpwe;jehs; gps;isf;Fj; jhNd ed;wha; 
gpjhthNy gpzpAlypd; NkNy Njhd;Wk; 
rpwe;jgpzp fzkhe;jk; fug;ghd; Njhlk;” 
- Foe;ij kUj;Jtk; ghythflk;  
 
vdNt ,e;Neha; mff;fhuzq;fisg; gw;wpaJ vdTk;> “gpjhthNy 
gpzpAlypd; NkNy Njhd;Wk;” vd;gjhy; rpj;j kUj;Jtjjpy; 
mff;fhuzq;fSf;F Kjw;fhuzk; “je;ij” vd;gJk; GydhfpwJ. 
 
 mJ vt;thnwdpy; je;ijapd; Rf;fpyNjhlk; jhapd; ehjj;Jld; 
fyg;GWfpd;wNghJ cz;lhFk; Neha; fzk; (m) fh;g;gr;R+L vd 
mwpag;gLfpwJ 
 
 
 
 
 
 
fh;g;gr;R+l;bdhy; cz;lhtJ khe;jj;jpd; 
njhlh;r;rpahf cz;lhtJ 
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fytpapy; Vw;gLk; tpfw;gk;: 
 
  jhahdts; jiyf;F vz;nza; Nja;j;J Fspj;j gpd; czT 
cz;L> kaf;fk;> Nfhgk;> jhfk; Kjypatw;why; gLj;J cwq;fp 
mjd; fhuzkhf Nky; Nehf;Fq;fhy; kpFjpg;gl;L ,Uf;Fk; fhyj;jpy; 
GUl irNahfk; nra;jhYk; Mltd; fhiyapy; gioaJ cz;lTld; 
type;J ngz;izg; Gzh;e;J>  ntapypy; jphpe;jgpd; ,utpYk; 
,uhTzT cz;l clNdAk; Gzh;e;jhYk; moyhdJ fpsh;r;rpAw;W 
R+L cz;lhFk;. ,g;gbg;gl;l fhyj;jpy; jq;fp gpwf;Fk; Foe;ijf;F 
fh;g;gr;R+L cz;lhfp> khe;jk; kw;Wk; fz Neha; Vw;glf; $Lk;.      
ghythflk; -  khe;jfzk;  
fU cw;gj;jpapy; thAf;fspd; gq;F 
“tpsq;Ffpd;w mghdthA ntspapdpw;Fk; 
tpe;JTld; gpuhzthA gpdq;f shFk; 
fyq;Ffpd;w cjhddJ fUit tsh;f;Fk; 
fUtjw;Fs; tpid%d;Wk; fyf;Fk; ghU” 
 
  vd;W A+fp Kdpth; $Wtjhy; mghdd; ntspapypUg;gjhfTk;> 
gpuhzthA tpe;JTld; cl;nry;YtjhfTk;> mJ jpuz;l ehjj;ijg; 
gy gpd;dq;fshf;FtjhfTk;> fUit cjhdthA tsh;g;gjhfTk;> 
fUtpy; tpidfs; %d;Wk; Nrh;tjhfTk; czuyhk;. 
 
NkYk; gpuhzthA tpe;Jtpw;F capNuhl;lk; mspg;gjhy; gpuhzd; 
ghjpg;gilAk; NghJ fUthdJ Nghlzpf;fg;glhky; fUcw;gj;jpapy; 
FiwT Vw;gl;L> moy; Fw;wk; tsh;r;rp mile;J> fUtsh;e;j gpd;Gk;> 
mf;Fw;wk; ehs;gl tsh;e;J fzj;jpd; FwpFzq;fisj; 
Njhw;Wtpf;fpd;wJ. 
 
“cd;dpa fh;gf; Fopahk; ntspapNy 
gd;dpa ehjk; gfh;e;j gpUjptp 
td;dpAk; thAT khAWQ; Rf;fpyk; 
kd;dpa rkdha; tsh;f;F KjfNk” 
- jpUke;jpuk; 
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NkYk; 
 
“ghd;ik vd;w tpe;jq;Nf CWk;nghJ 
ghAklh td;dpNahL thAjhNd” 
- mfj;jpah; ty;yhjp ehbE}y; 
 
vdNt fUtpw;F tpe;JtpypUe;J thjk;> gpjjk; vd ,uz;L 
jhJf;fSk;> cjfePh;> ehjk; ,tw;wpypUe;J fgKk; fpilf;fpd;wJ. 
 
 “td;dpAk; thAT khAWQ; Rf;fpyk;” vd;W $wg;gLtjhy;> 
fUTWk; fhyj;jpy; thAthdJ tpe;Jit vLj;Jr; nry;Yk; vd;gJk;> 
td;dp vd;Dk; moy; mjid fhj;J epw;Fk; vd;gJk; Gydhfpd;wJ. 
,j;jPAk;> thATk; jd;dstpy; kpFjpg;gl;L fUitj; jhf;Fk; NghJ 
mJ fdypy; mbg;gl;l gpz;lkhf khwp> “fzk;”  cz;lhfpwJ 
vd;gJ rpj;j kUj;Jtj;jpd; JzpT. 
 
fzk; Njhd;Wtjw;F jha; fhuzkhjy; 
“IaJ $bw; nwd;why; mhpitah; Jaue; jd;dhy; 
nra;agw; GdyUe;jp nrwpry Njhle; jd;dhy; 
igau ty;F yhSk; grpAl dpUj;j yhYk; 
Ja;aNjhh; Fotp fl;Ff; fzq;fSe; Njhd;W kd;Nw” 
 
    - mNahj;jpjhrh; ghythflk; 
 
 Iak; jd;dstpy; kpFjy; 
 mhpitaUf;F (20 - 25 taJ epuk;gpa ngz;) Vw;gLk; Jauk; 
 ghY}l;Lk; ngz;fs; grpAldpUj;jy; 
 ryNjhlk; 
 
,f;fhuzq;fshy; mj;jhia mz;b thOk; Foe;ijapd; cly; 
ghjpf;fg;gl;L Foe;ijfSf;F fzNeha; Vw;gLfpwJ. 
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Neha; Njhd;Wk; taJ: 
 
 ,J Foe;ijfs; ghYk; Fbj;J NrhWk; cz;Zk; gUtj;jpy; 
cz;lhFk; NehahFk;. 
 
‘vd;dNt fzk; %d;W tUle; njhl;Nl 
Vohz;L kl;L kpUf;Fq; fhyk;’ 
 vdNt ,J Foe;ijapd; %d;whz;L Kjy; Vohkhz;L tiu 
tUk; Neha; vd mwpayhk;. NkYk; fPo;f;fz;l ghly;fspy; ,J 
Foe;ijapd; 12 taJ tiuapYk; fhZk; Neha; vd;W mwpayhk;. 
 
‘vd;w Njuh; fiz flhKkpg;gb naOe;J nghq;fp 
epd;wNgh; gjpndl;L jhdpiwe;jpU khz;bd; Nkyha;f; 
fd;wpa ghyh; nka;apw; gd;dpnuz;lhz;L fhWk; 
epd;wpL nkd;W Kd;dhzpfo;j;jpdd; Kdptdd;Nw’ 
 
        - guuhrNrfuk; 
 
‘kyKQ; ryK kpfj; jPa;e;J khh;gpyjpf Ruq;fhAk; 
kyKk; tapW kpf nthpAk; tskha; jiyAkpf kaf;Fk; 
ryKk; tus;jP jhd; FiwAk; rz;lhsk; NghYl; Rukhk; 
jyNk gdpuz;lhz;L kl;Lk; jdjha; tU{cq; FzkpJNt’ 
        - ghythflk; 
fzj;jpd; tiffs;: 
 
1. mNahj;jpjhrh; ghythflk; - 24 
 
1. tsp fzk; 
2. mow; fzk; 
3. Ia fzk; 
4. khe;j fzk; 
5. ePh;f; fzk; 
6. gpuspf; fzk; 
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7. R+yp fzk; 
8. Rop fzk; 
9. kfh fzk; 
10. CJ fzk; 
11. tus;fzk; 
12. nfhjpg;G fzk; 
13. tPf;f fzk; 
14. gpwf;fzk; 
15. me;jf fzk; 
16. ke;jhu fzk; 
17. vhp fzk; 
18. ePuhk fzk; 
19. Mk fzk; 
20. Kf;F fzk; 
21. %y fzk; 
22. Nguhk fzk; 
23. ,uj;j fzk; 
24. rpq;fpkhe;j fzk; 
 
2. Mtpaspf;Fk; mKj Kiwr; RUf;fk; - 23 tif 
 
1. thj fzk; 
2. gpj;j fzk; 
3. rpNyj;Jk fzk; 
4. khe;j fzk; 
5. ePh;f;fzk; 
6. gpusp fzk; 
7. R+iy fzk; 
8. Rop fzk; 
9. kfh fzk; 
10. CJ fzk; 
11. twl;rp fzk; 
12. nfhjpg;G fzk; 
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13. tPf;f fzk; 
14. gpwf; fzk; 
15. Mk fzk; 
16. twl;rp fzk; 
17. Kf;F fzk; 
18. Nghh; fzk; 
19. ,uj;j fzk; 
20. er;R khe;j fzk; 
21. CJ khe;j fzk; 
22. vhp fzk; 
23. ke;jhu fzk; 
 
3. [Ptul;rhkph;jk; - 8 tif 
 
  1. R+ypfzk; 
  2. Kf;F fzk; 
  3. Mk fzk; 
  4. Njiu fzk; 
  5. kfh fzk; 
  6. Rop fzk; 
  7. fop fzk; 
  8. tus; fzk; 
 
4. gps;isg; gpzp thflk; - 8 tif 
 
1. tus; fzk; 
2. %y fzk; 
3. rPj fzk; 
4. ,ja fzk; 
5. kfh fzk; 
6. ky fzk; 
7. Fz;lypa fzk; 
8. ePh; fzk; 
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5. guuhr Nrfuk; ghyNuhf epjhdk; - 18 tif 
 
1. thj fiz  
2. gpj;j fiz 
3. Ruf; fiz 
4. mj;jpRu fiz  
5. tul;fiz 
6. thyre;jpu fiz 
7. kNfe;jpu fiz 
8. J}f;F fiz 
9. mdw; fiz 
10. tPq;F fiz 
11. ntSg;G fiz 
12. rj;jp fiz 
13. ,uj;j fiz 
14. %yf; fiz 
15. fUq;fiz 
16. kQ;rl; fiz 
17. epyf;fiz 
18. ntg;G fiz 
 
6. Mj;kul;rhkph;jnkd;Dk; itj;jpa rhurq;fpufk; - 25 tif 
1. thj fzk; 
2. gpj;j fzk; 
3. Nrj;Jk fzk; 
4. khe;j fzk; 
5. ePh;f;fzk; 
6. R+iy fzk; 
7. gpuspfzk; 
8. CJ fzk; 
9. Ropfzk; 
10. kfh fzk; 
11. tul;fzk; 
12. nfhjpg;G fzk; 
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13. gpwf;fzk; 
14. tPf;f fzk; 
15. Mkf;fzk; 
16. Njiuf;fzk; 
17. Kf;Ff;fzk; 
18. %yf;fzk; 
19. NghHf;fzk; 
20. ,uj;jf; fzk; 
21. tp\khe;j fzk; 
22. CJkhe;j fzk; 
23. me;jf fzk; 
24. ke;jhu fzk; 
25. vhpfzk; 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 20 
 
fzj;jpd; FwpFzq;fs;: 
 
khh;G> EiuaPuiy jhf;fp tUk; FwpFzq;fs; 
 
 Nky;%r;R cz;lhFk; 
 ,Uky; 
 njhz;il fk;kyhf Ngry; 
 cly; fzfzg;G 
 mdy; tPRtJ Nghd;w cl;Ruk; 
 khHG $k;G Nghy; vOk;gy; 
 khh;gpy; mjpf Ruk; 
 
mfl;ilg; gw;wp tUk; FwpFzq;fs; 
 
 tapW fopjy;> fha;jy; 
 kyk; vz;nza; frpTs;sjhf ,Uf;Fk; 
 kythapy; Cd; fOtpa ePuhfTk;> rPjkhfTk;> ,uj;jkhfTk;> 
rPjKk; ,uj;jKk; fye;Jk; NgjpahFk;. 
 tapW cg;Gk; 
 kyk; jPa;e;J ePh; RUq;Fk; 
 grpj;jP FiwAk; 
 
nghJ FwpFzq;fs;: 
 
 fz;fs; ntUz;L ghh;j;jy; 
 cr;rp FoptpOjy; 
 tha; cyuy; 
 ePh; Ntl;if 
 if fhy;fs;> Kfk; ,it fWj;Jf; fhZk; 
 kaf;fk; cz;lhFk; 
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Kf;Fw;w NtWghL  
 
     fHg;gr;#L → fzk;     khe;jk;  fzk; 
Rf;fpy RNuhzpj Njhlk; 
        
jhapd; czthjp nray;fspy; 
khWghL 
         
gpuhzd; 
mghdd; ghjpg;G 
cjhdd; 
        
moy; Fw;wk; tsh;r;rpailjy; 
        
fh;g;gr;#L Vw;gly; 
        
Foe;ij gpwe;jJk; tsh;r;rpAw;w 
moyhdJ fgj;jpd; ,Ug;gplkhd 
khHigg;gw;Wjy; 
        
thAitg; gw;wp mOj;jy; 
        
Iak; jd;dstpy; kpFjy; 
        
fzj;jpd; FwpFzk; Njhd;Wjy; 
 
Kf;Fw;w khWghL 
(Foe;ijfSf;F)  
         
tapw;wpy; Iak; kpFjp (fpNyjfk; 
ghjpg;G) 
         
jPf;Fw;wk; ghjpg;G 
(mdw;gpj;jk; rkhf;fpdp ghjpg;G) 
         
cjhdd;   
mghdd; 
         
khe;jk; Vw;gly; 
         
khe;jk; njhlh;e;J epiyj;jy; 
         
gpuhzd;> mghdd;> tpahdd;> 
cjhdd; 
rkhdd; - ghjpg;G 
         
Iak; jd;dstpy; kpFjy; 
         
mfl;ilg; gw;wpa IaKk; 
khHigg; gw;wpa IaKk; fzj;jpd; 
FwpFzq;fisj; 
Njhw;Wtpf;fpd;wJ. 
ghjpg;G 
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tpsf;fk;: 
 
1.  fh;g;gr; R+l;bdhy; Vw;gLk; Kf;Fw;w NtWghL 
 
  czthjp nray;> Kaw;rp> mf> Gw fhuzq;fspdhy; Vw;gLk; 
Rf;fpy RNuhzpj Njhlq;fshy;> tpe;JTld; cl;nry;Yk; gpuhzd;> 
ntspapypUe;J fhf;Fk; mghdd;> fUit tsh;f;Fk; cjhdd; Mfpa 
thAf;fs; ghjpg;gile;J moy; Fw;wk; kpFjpg;gl;L> fh;g;gr;R+L 
Vw;gLfpd;wJ. 
 
 ,t;thW kpFjpg;gl;l moyhdJ> fgj;jpd; ,Ug;gplkhd khh;igg; 
gw;wp Iaj;ij tsh;r;rpAwr; nra;J fzj;jpd; FwpFzq;fisj; 
Njhw;Wtpf;fpd;wJ. 
 
2. khe;jk;    fzk; Kf;Fw;w NtWghL 
 
 jhapd; czthjp nray;fspy; khWghL Vw;gl;L> mj;jhia 
mz;b thOk; Foe;ijfSf;F Kf;Fw;wk; khWgl;L> tapw;wpy; Iak; 
kpFe;J fpNyjfk; ghjpg;gilfpd;wJ. gpd;dh; moy; Fw;wk; ghjpg;G 
mile;J mdw;gpj;jk;> rkhf;fpdp ,it jd;dstpy; Fiwtjhy; 
tapw;wpy; Iak; kpFe;J grpapd;ik>  czT cz;z ,ayhik> 
nrhpahik Mfpait Vw;gLfpd;wJ. ,jdhy; cjhdd;> mghdd; 
,it ghjpg;gile;J ke;j epiy Vw;gl;L khe;jk; Vw;gLfpd;wJ. 
khe;jk; njhlh;e;J epiyj;jhy; jPf;Fw;wj;jpd; ghjpg;G thAitg; gw;wp 
mOj;jp gpuhzd;> mghdd;> tpahdd;> cjhdd;> rkhdd; Mfpa 
thAf;fs; ghjpg;gile;J fgkhdJ mjd; ,Ug;gplkhd khh;gpy; 
tsh;r;rpAw;W> thAtpd; ,aw;ifNahl;lj;ijj; jLf;fpwJ. ,t;thW 
mfl;ilg; gw;wpa IaKk;> khh;ig gw;wpa IaKk; jd; mstpy; 
tsh;r;rpAw;W fzj;jpd; FwpFzq;fs; Njhd;Wfpd;wJ. 
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Ropfzk; - rpj;j kUj;Jt Fwpg;Gfs;  
 
  RopnaDq; fzNk nrhy;ypd;  
   RopaNt Rthrk; thq;Fk; 
  espUld; RuKe; Njhd;Wk; 
   eadk;gQ; rilj;Jf; fhZk; 
  njspTld; re;J nehe;J 
   jpiff;fneQ; nrhpg;Gf; fhZk; 
  FopANk Ar;rp jhopw; 
        Fzkp/ jwpe;J nrhy;Ny 
 
  kpd;Nd Nfsha; Ropfze;jhd; 
         NkTk; the;jp apUkYz;lhk; 
  nghd;Nd KfK khh;Gfz;lk; 
        Gilj;Jf; fhZ Kz;ikapJ 
  nrhd;Ndhk; tapW kPuy; neQ;R 
         njhz;il ehT kpit nte;J 
  md;id Kiyg;ghy;  Fbahky; 
        mywp aOkP jwpthNa 
 
  nrUK ehiu Nghw;WtSk; 
       Nrh;f;if fhYq; Fsph;e;jpUf;Fk; 
  nghUKk; tapW jhD}Jk; 
       nghy;yhr; RuK kpfTz;lhk; 
   mhptha; EiuAq; NfhioAkhk; 
        mUeh tuSq; fz;nrhUFk; 
  jUNk kQ;rs; Kfkaf;fk; 
        jiyA NehthQ; RopfzNk 
 
          - ghythflk;   
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nghUs; :  
 
 Rthrk; Ropj;J thq;Fk; -  %r;R fbdkhf ntsptUjy; 
(T.V. rhk;grptk;gps;is Vol – IV) 
 espUld; Ruk; 
 fz; gQ;rilj;J fhZk; 
 re;J Nehjy; 
 neQ;nrhpjy; (neQ;Rf;fhpj;jy;)  - mRPuzj;jhy; khh;G my;yJ 
njhz;ilapy; cz;lhFk; Xh; tiff; fhpg;G (TV rhk;grptk;gps;is 
3056) 
 the;jp 
 ,Uky; 
 Kfk;> khh;G> fz;lk; Gilj;J fhZk; 
 tapW> <uy;> neQ;R> njhz;il ehT nte;J fhzy; 
 ghYz;zhik 
 ehiu Nghy; Jtsy; 
 if> fhy; Fsph;jy; 
 tapW Cjy; 
 Nfhio Eiujy; 
 ehtwsy; 
 fz; nrhUfy; 
 Kfk; kQ;rspj;jy; 
 jiyNehjy; 
 kaf;fk; cz;lhjy; 
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kjiyNeha; njhFjp – II 
 
 “vd;doy; RuKk; Njhd;wp ,UkYk; Rthr Kz;lhk; 
  cz;ikaha; neQ;nrhpj;J cr;rpAk; FopAk; gpd;Nd 
 Fd;Dly; nehe;J ghyd; Fioe;JNk myWk; ghU 
  Ez;zpa Fzq;fs; fz;lhy; Rop fznkz;zyhNk 
 vz;zNt ghYz;zhJ <uYk; tapWk; neQ;Rk; 
  mz;zNy njhz;il ehT fjpg;Gld; nte;J Gz;zha; 
 tz;z iffhy; FspUk; tapwJ nghUkpf;fhAk; 
  gd;dyha; fz;nrhUfp ghh; ehtwSe;jhNd” 
 
nghUs; : 
 
 moiyRuk; -  fzr;R+l;bdhy; Foe;ijfSf;F cly; mjpf 
ntg;gk; nfhz;L Vw;gLk; fha;r;ry; 
 ,Uky; 
 Nky;%r;R cz;lhjy; 
 neQ;nrhpjy; 
 cr;rp Fopjy; 
 cly; Fd;wp thly; 
 <uy;> tapW> neQ;R> njhz;il> ehT nte;J Gz;zhjy; 
,t;TWg;Gfspy; jPFw;wk; kpFe;j jhgpjj;ij vOg;gp Nfhioia 
cz;lhf;Fk;.                 – (,iug;G - Neha;ehly; -II)  
 if> fhy; Fsph;jy; 
 tapW nghUky; 
 fz; nrhUfy;   
 ehtwsy; 
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gps;isg; gpzpthflk;  
 
   “ghy;Kiyaha; ePNfsha; kz;zpy; gpwe;J ghyfUf;F  
    <uy; nte;J Ropfzkha; ,UkYz;lhk; tha; ,dpg;ghk; 
   ehwtk; Nghyj;J tz;L ehrp ,uz;Lk; vLj;njhpAk; 
 ghhpYs;s ghyfUf;F ghhPh; ,jidg; ghhPNu 
 
kpd;Nd Nfsha; Ropfze;jhd; 
   Nky;Rthrk; NkY Kz;lha; 
  gpd;Nd khh;G Kfk; euk;Gk; 
   Gilj;Jf; fhZk; cz;ikapJ 
  nrhd;Ndhk; tapWkPuy; neQ;Re; 
   Njhd;W kjukpit nte;J 
  md;id KiyAk; Fbahky; 
   mywpa OkP jwpthNa 
     
nghUs; : 
 
 <uy; nte;J fhZk; 
 ,Uky; cz;lhFk; 
 ehiu Nghy; Jtsy; 
 ehrp ,uz;Lk; vLj;jnjhpAk; (ehrp ,uz;Lk; NkYf;F vOk;gp 
,wq;Fjy;) 
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A CORRELATIVE STUDY OF ETIOPATHOGENESIS AND SYMPTOMS 
OF SUZHIKANAM WITH CHILDHOOD ASTHMA 
 
Etiopathogenesis  of  kanam  (fzk; Njhd;w fhuzq;fs;) 
1. khe;jj;ij njhlh;e;J fzk; Vw;gLjy; : 
  Foe;ijfSf;F khe;jNeha; gyKiw te;J mJ Kw;wpYk; 
Fzkilahky; clk;gpd; cs; gFjpapNyNa ,Ue;J Kw;wp 
,Ug;gjhy; fzk; cz;lhFk;. 
        - ghythflk; 
 
 “md;dKk; ghYk; nea;Ak; 
  mOfpa goKe; Njq;fha; 
 gpd;idAk; fliy nty;yk; 
  nghpaNjhh; fjypg; gz;Lk; 
 jpd;DNkhh; fhye; jd;dpy; 
  jPnad ntJk;G khfpy; 
 xd;WW gps;isf; Fj;jhd; 
  cte;JNk khe;j Kz;lhk;” 
- ghythflk; 
 
  Hence from the above literature evidence, it is clear that the imbalance 
nutrition in Mother’s diet is a major and significant cause for the 
development of Mantham in children. 
 
Ingestion of certain foods like Cow’s milk, Pea nut, soya, egg and 
certain proteins may cause allergic reaction to the lactating mother with a 
rise in serum IgE. The high levels of IgE in the lactating Mother is 
transmitted to the child leading to Atopic disease in the child. (Official 
journal of American Academy of Pediatrics) 
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  Dietary influences in early life, shape the plasticity of the immune 
system and food sensitivity is an important factor in the development of 
allergy in the first 1-2 years of life (D. Behera, Bronchial Asthma) 
   Food allergy is a group of disorder in which symptoms result from 
immunologic response to specific food antigen in children during  1-3 years 
of life. (Nelson, Textbook of Pediatrics) 
  This correlates with Siddha Literature evidence that Mantham is a 
“Palparuva Noi” occuring during 1-3 years of life. (Balavagadam page-126) 
 
,jid> 
 “Mz;nlhd;iwj; njhl;Nl afy;%d;wh khz;lsTk; 
 jhz;LNk khe;jNeha; jhd;” 
 
 vd;W ghythfl E}ypy; $wg;gl;L cs;sJ. 
 
 “jhz;LNk khe;j Neha;” vd $wg;gLtjhy;> khe;j Neha; 
njhlh;e;J epiyj;jhy; “fzk;” Vw;gLk; (taJ 3 – 12) vd;gJ 
GydhfpwJ. 
  vdNt khe;j tiffspy; xd;whd “Rop khe;jk;” njhlh;e;J 
epiyj;jhy; mJ Kjph;e;J  “Ropfzk;” cz;lhfpwJ vdTk; 
njhpfpwJ. 
 
Rop khe;jk; - FwpFzk; 
 Jwg;GkpFk; fha;r;rYld; Rthre; Njhd;wy; 
  J}f;fkJ gpbahJ njhq;fpf; fha;jy; 
 ,iwg;ngLj;J tpf;fYld; tpyhtpw; gs;sk; 
  Ve;J nfhq;if FbahJ tPq;fp  dhw;Nghy; 
 ntWg;ghh;fs; rpWtd;Nky; ,dpNa njd;ghh; 
  NtNweP kde;jtpf;f Ntz;lhQ; nrhd;Ndd; 
 cwg;ghd Fwpfspit jhKq; fz;lhy; 
  XXX Ropkhe;j nkd;W nrhy;Ny  - ghythflk; 
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  Therefore suzhimantham probably correlates with signs and symptoms 
of Bronchiolitis and Croup symptoms a predilector of Asthma in future. 
 
2. fh;g;gr;R+l;bdhy; fzk; Njhd;Wjy; 
 “njhifahd fzq;fs; vy;yhk; fh;g;gr;R+L” 
      - mNahj;jpjhrh; ghythflk; 
 “Rf;fpyj;jpy; RNuhzpjq; fyf;Fkd;W 
 G+e;jpLk; tpahjp %d;Wk;” 
      - jd;te;jphp ehb 
 “kpfpDk; FiwapD Neha; nra;A E}Nyhh;  
 tspKjyh ntz;zpa %d;W” 
      - jpUts;Sth; 
 
  Nkw;fz;l Fwpg;Gfspd; %yk; fzk; fUtpNyNa Njhd;Wk; 
mff;fhuz Neha; vd;gJk;> Rf;fpy RNuhzpj FiwghLfshy; 
fh;g;gr;R+L Vw;gLfpd;wJ vdTk; mwpayhk; 
 
 Hence “fh;g;gr;R+L” Parallells with the concept of  “Genetic basis of 
Atopic diseases” 
  The risk of allergic diseases in a child approaches  50% when one 
parent is allergic and 66% when both parent are allergic. 
  Atopic diseases have a strong familial predisposition with  60% 
heritability in twin studies of Asthma and Atopic dermatitits. 
  The genetic defects affecting one or more arms of immune system 
result in primary immune deficiencies and the affected child may not be able 
to contain the pathogen or develop and immune response to prevent 
recurrence  
     (Nelson, Text book of Pediatrics Vol-2) 
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3. Foe;ijf;F fzk; Njhd;w jha; kw;Wk; Gw;r;R+oy;fs; fhuzkhjy;: 
 “IaJ $bw;nwd;why;”..... 
  jhdKs;s Nrj;J ke;jh dpsfpy; ntg;G 
  rakPis apUky; ke;jhu fhrk;” 
 
 mhpitah; Jauk;> ghY}lLk; ngz;fs; grpAldpUj;jy;: 
 
Effect of Anxiety in Lactating Mothers: 
 
Hunger, Anxiety, depression in a lacatating mother 
↓ 
Impair milk ejection reflex 
↓ 
Decreases oxytocin secretion 
↓ 
Deficient feeding 
↓ 
Baby is susceptible to infections and allergy due to Immune deficiency 
(Journal of Nutrition 2001, American society for Nutritional 
sciences) 
 ryNjhlk; (Fbj;jy; FspaYf;F Mfhj ePiu cgNahfpg;gjhy; 
Vw;gLtJ) 
Infections due to Water pollution 
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PARALLEL ANALYSIS OF SYMPTOMS OF SUZHI KANAM WITH THAT 
OF CHILDHOOD ASTHMA 
 
(GENERAL SIGNS AND SYMPTOMS) 
 
,Uky; Cough 
Rthrk; Ropj;J thq;Fjy; (%r;R 
fbdkhf ntsptUjy;) 
Prolonged expiration and expiratory 
wheeze 
the;jp Mechanical vomiting due to severe cough. 
The vigorous contractions of abdominal 
muscles and diaphragm  that occur during 
severe coughing may result in vomiting 
ghYz;zhik Nasal obstruction and breathing difficulty, 
interferes with feeding 
fz; gQ;rilj;J fhZk; Tried looking eyes due to repeated night 
awakening due to  cough and 
breathlessness 
EiuaPuy;> neQ;R> njhz;il nte;J 
Gz;zhjy; 
Inflammatory changes due to chronic 
presistent  cough and breathing difficulty  
tapW nghUky; Abdominal bloating and discomfort due to 
mouth breathing. Asthma itself able to 
induce Gastro intestinal symptoms such as 
abdominal distension due to aerophagia. 
neQ;nrhpjy; Sour eructations in the esophagus and 
heart burn due to GER. This is due to the 
Increase in transdiaphragmatic of pressure 
that increases the prevalence of 
symptomatic GER in 70% of asthmatics 
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cly Fd;wp thly; Stunted growth and poor weight gain in 
children with recurrent respiratory tract 
infections. 
Ruk;> re;J Nehjy;>   Fever and associated symptoms may 
accompany asthma, as asthma is 
commonly provoked by viral infections 
and Upper respiratory tract infection in 
children. 
Kfk;> khh;G> fz;lk; Gilj;J 
fhzy; 
Increased Anterio posterior diameter of 
chest - Sign of Acute severe 
Exacerbations of Asthma. 
if>  fhy; FspUk; Altered sensorium 
ehtwSk;  Drying of lips from continuous mouth 
breathing 
ehrp vLj;njhpAk; Nasal Flaring – a Manifestation of 
respiratory distress in severe exacerbation. 
kaf;fk>; jiy Nehjy;> 
fz;nrhUfy;> 
Coma / Semicoma, Confusion, Headache 
due to Hypoxia 
Kfk; kQ;rspj;jy; Facial pallor due to hypoxia 
cr;rp Fopjy; Depression of anterior fontanelle 
indicating the serious condition of infant 
due to exacerbation of the disease 
Nfhio EiuAk;  Excess mucus production and 
inflammatory exudate in the airways 
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‘ehiu Nghy Jtsy;’  
(ehiu – Stroke) 
 
They are long and thin legged birds with 
long neck. 
They communicate by weak moans or 
grunts as they lack a voice box. 
They walk slowly and make short distant 
movements. 
They sleep on standing with neck bent 
back on its head resting between its 
shoulders 
This can be compared with 
elevated shoulder and hunch back position 
adopted due to airway obstruction. 
Also, the anterior flexion of head 
during inspiration known as ‘Head 
bobbing’ can occur in asthmatic infants, 
which is a feature present in storks and 
few other birds. 
Their Beaks remain partly open most of 
the times which can be compared with  
‘Mouth Breathing’ 
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Kf;Fw;w ,ay;: 
 
rpj;j itj;jpa mbg;gil jj;Jtj;jpd;gb cly; 
,aq;Ftjw;Fhpa caph;jhJf;fs; thjk;> gpj;jk;> fgk; vdf; $wg;gLk;. 
,k;%d;W rf;jpfSk; jk; mstpy; nrt;tNd nray;gLk; NghJ cly; 
jhJf;fs; Nehapd;wp ,aq;Ffpd;wd. ,it jk; epiykhwp 
nray;gLk;NghJ clypy; Neha; cz;lhf fhuzkhfpd;wd. 
 
thjk;  
thjk; thOkplk;: 
  tspahdJ mghdk;> kyk;> ,lfiy. ce;jpapd; fPo; %yk; 
fhkf;nfhb> ,Lg;G> vYk;G> Njhy;> euk;Gf; $l;lk;> fPy;fs;> 
kaph;f;fhy;> Cd; vd;Dk; ,lq;fspy; tho;tjhFk;. 
 
tspapd; ,aw;ifg; gz;G 
 
xOq;Fld; jhNjo; %r; Nrhq;fp ,aq;f 
vOr;rpngw vg;gzpAkhw;w vOe;jphpa 
Ntfk; Gyd;fSf;F Nktr; RWRWg;G 
thfspf;Fk; khe;jh;f;F 
   
thA ,aw;if epiyapy; epd;W Cf;fKz;lhf;fy;> %r;Rtply;> 
thq;fy;> kdnkhop nka;fSf;F nraiyj;juy;> kyk; Kjypa 
gjpdhd;F tpiuTfis ntspg;gLj;jy;> VO clw;fl;Lfs; kw;Wk; 
Ik;nghwpfSf;F td;ik nfhLj;jy; Mfpa nray;fisg; GhpAk;. 
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,/J xd;whapUg;gpDk; jd; ,lk;> njhopy; Kjypatw;why; gj;J 
tifg;gLk;. 
 
thjk; nray; Ropfzj;jpy; fhzg;gLk; 
epiy 
gpuhzd; %r;Rtply;> thq;fy; czit 
nrhpj;jy;. 
ghjpg;G (%r;Rtply;> 
thq;fypy; rpukk;) 
mghdd;  kyryj;ij js;Sk; md;drhuj;ij 
Nrh;g;gpf;Fk;. 
ghjpg;G (kyr;rpf;fy;> 
cly;td;ik Fiwjy;) 
tpahdd;  cWg;Gfis ePl;l klf;f nra;Ak;> 
cly; rhuj;ij epug;gpj;J cliy 
fhf;Fk;. 
ghjpg;G (cly; Fd;Wjy;) 
rkhdd; kw;w thAf;fis kpQ;r nthl;lhky; 
klf;fpr; rhpg;gLj;Jk;. 
ghjpg;G (gpw thAf;fis 
fl;Lg;gLj;Jtjpy; rpukk;) 
cjhdd;  Nky;Nehf;Fq;fhy; vdg;gLk; Ngr;Rf;F 
Kjw;fhuzk; Kaw;rp>  kNdhjplk; 
cz;lhf;Fk;. 
ghjpg;G (,Uky;> the;jp> 
Nky;%r;R> Ngr;nrhyp 
Fiwjy;> clw;Nrhh;T) 
ehfd;  vy;yh fiyfisAk; fw;Fk;gb 
nra;Ak;. fz; ,ikf;Fk;gb nra;Ak; 
ey;y gz;Gfis ghLtpf;Fk;. 
; ghjpg;G (gbj;jy;> 
tpisahly;  Nghd;w 
nray;fis nra;a rpukk;) 
$Hkd; nfhl;lhtp tplg;gz;Zk;. fz;jpwf;f> 
%lnra;Ak;.  fz;zPH tpog;gz;Zk;. 
,ay;G 
fpUfud; ehtpw;frpT> ehrpapw; frpT> Jk;ky;> 
,Uky;> grpia cz;lhf;Fk;. 
ghjpg;G (thapy; Nfhio 
Eiujy;> ,Uky;> %f;FePH 
gha;jy;> grpapd;ik) 
Njtjj;jd; Nrhk;gy;> Nfhgk;> J}q;fp vOk;NghJ 
mah;r;rp cz;lhFk;. 
ghjpg;G (rpy Ntis kpFe;j 
mrjp fhzy;) 
jdQ;nrad; ,we;Jtpbd; fhw;nwy;yhk; ntspg;gl;l 
gpd;dh; %d;whtJ ehspy; jiy 
ntbj;j gpd; jhd; NghFk;. 
- 
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gpj;jk;; 
 
gpj;jk; thOkplk;: 
 gpq;fiy> gpuhzthA> ePHg;ig> %yhf;fpdp> ,Ujak;> jiy> 
nfhg;Go;> ce;jp> ,iug;ig> tpah;it> ehtpY}Wfpd;w ePH> nre;ePH> 
rhuk;> fz;> Njhy; ,t;tplq;fspy; thOk;. 
 
moypd; ,aw;ifg; gz;G: 
 
grpjhfk; Xq;nfhspfz; ghHitgz; lj;J 
Urpnjhp rj;jp ntk;iktPuk; - crpj 
kjp$Hj;j Gj;jptdg; gspj;Jf; fhf;Fk; 
mjpfhhp ahq;fh doy; 
 
 moyhdJ> jd; ,aw;if epiyapy; epd;W nrhpg;gpj;jy;> 
ntk;ik> ghHit> grp> ePHNtl;if> Rit> xsp> epidg;G> mwpT> 
td;ik> nkd;ik vd;git cz;lhf;Fk;. 
 
gpj;jk; nray; Ropfzj;jpy; 
gpj;jj;jpd; epiy 
mdw;gpj;jk; ePHtbTs;s nghUs;fis tws 
nra;Ak;. czit nrhpf;Fk.; 
ghjpg;G (grpapd;ik  
nrhpahik) 
,uQ;rfgpj;jk; nre;ePiu kpFjpg;gLj;Jk;. rpyNtis ghjpg;G 
(ghz;L) 
rhjfg;gpj;jk; mwpT> Gj;jpiaf; nfhz;L> 
tpUg;gkhd njhopiy epiwNtw;Wk;. 
ghjpg;G (md;whl 
Ntiyfis nra;tjpy; 
rpukk;) 
gpuhrfk; NjhYf;F xspia nfhLf;fpwJ. rpyNtis ghjpg;G 
(Njhypy; mhpg;G) 
MNyhrfk; fz;fspy; tho;e;J tbtj;ij 
mwpar; nra;Ak;. 
,ay;G. 
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fgk; 
 
Iak; thOkplk;: 
 
 rkhdthA> RopKid> tpe;J> jiy> Mf;fpid> ehf;F> 
cz;zhf;F> nfhOg;G> kr;ir> FUjp> %f;F> khHG> euk;G> vYk;G> 
%is> ngUq;Fly;> fz;> fPy;fs; ,it Iak; thOkplk;. 
 
Iaj;jpd; ,aw;ifg; gz;G: 
 
 jplkPA nkd;gpizg;Gj; jpz;ikAw;w ahg;Gk; 
   mlNyh; tOtOg;Gk; Mf;iff; - fplh;f;F 
 ntUthg; nghWikAk; Nkyhd fhg;ghk; 
   ngUikj;jh ikankdg; NgR. 
 
fgkhdJ typT> vd;G %l;LfSf;F td;ik> Mw;wy;> 
tOtOj;jd;ik> clYf;Fj; Jd;gk; NeUq;fhy; mQ;rhky; 
nghWj;Jf; nfhs;sy; Mfpa ngUikia cilaJ. 
 
fgk; nray; Ropfzj;jpy; fgj;jpd; 
epiy 
mtyk;gfk; EiuaPuypy; ,Ue;J kw;w 
ehd;F Iaq;fl;L gw;Wf; 
Nfhlha; ,Uf;Fk;. 
ghjpg;G (%r;R tpl rpukk;) 
fpNyjk; ,iug;igapy; ,Ue;J 
czT ePH Kjypatw;iw  
<ug;gLj;jp nrhpg;gpf;Fk.; 
ghjpg;G (nrhpahik) 
Nghjfk; ehtpdpd;W Ritia 
mwptpf;Fk;. 
rpyNtis ghjpg;G (Ruk;) 
jw;gfk; jiyapdpd;W ,U 
fz;fl;Fk; Fsph;r;rpiaj; 
jUk;. 
rpyNtis ghjpg;G (fz; 
rptj;jy;) 
re ;jpfk; fPy;fis xd;Nwhnlhd;W 
nghUj;jpj; jsu nra;Ak;. 
,ay;G 
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clw;fl;Lfs;: 
   
rhuk; : cliyAk; kdijAk; Cf;fKwr; nra;jy; Ropfzj;jpy; rhuk; 
ghjpg;giltjhy; clw;Nrhh;T> cly; Fd;wp fhzg;gly; 
Mfpait cs;sJ. 
nre;ePh; :   mwpT> td;ik> xyp>  nrUf;F> xsp ,itfis epiyf;fr; 
nra;tJ. 
Ropfzj;jpy; rpy Nehapdh;fl;F ntSg;G cs;sjhy; nre;ePh; 
ghjpf;fg;gLfpwJ. 
Cd; clypd; cUtj;ij mjd; njhopw;fpzq;f mikj;jYk; vd;ig 
tsh;j;jYkhFk;. 
,J Ropfzj;jpy ngUk;ghYk; ghjpg;giltjpy;iy rpy Ntis 
ePz;l ehl;fshf Neha;epiy fhzg;gl;lhy; Cd; Fiwe;J cly; 
Fd;wp fhZk;. 
nfhOg;G xt;nthU cWg;Gk; jj;jk; nraiy ,aw;Wk;NghJ fbdkpd;wp 
,aq;f mtw;wpw;F nea;g;Gg; gir Cl;b cjtpGhpfpwJ. 
ePz;l ehl;fshf Neha;epiy fhzg;gl;lhy; ghjpg;G. 
vd;G cliy xOq;Fgl epWj;jp itj;jy;> nkd;ikahd 
cWg;Gfisg; ghJfhj;jy;> cly; mirtpw;F mbg;gilaha; 
,Uj;jy; Mfpa nray;fis nra;Ak; ,J Ropfzj;jpy; 
,ay;ghfNt cs;sJ. 
%is vd;Gf;Fs; epiwe;J mitfSf;F td;ikAk; nkd;ikAk; 
jUtJ. 
,J Ropfzj;jpy; ghjpg;G miltjpy;iy. 
ntz;zPh; / 
RNuhzpjk; 
jd;idnahj;j cUtg;ngUf;fpw;F ,lkhfpa fUj;Njhw;wj;jpw;F 
Kjyha; epw;gJ. 
 
  
,e;j VO clw;whJf;fSk; jj;jk; ,aw;ifg; gz;NghL ,Ue;jhyd;wp 
mitfs; nra;Ak; njhopy; ed;F eilngwhJ. 
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gUtfhyq;fs;: 
 
1. fhh;fhyk;   - Mtzp> Gul;lhrp  (August & September)  
2. $jph;fhyk;   - Ig;grp> fhh;j;jpif (October & November) 
3. Kd;gdpf;fhyk;     - khh;fop> ij  (December & January) 
4. gpd;gdpfhyk;      - khrp> gq;Fdp  (February & March) 
5. ,sNtdpy;fhyk;   - rpj;jpiu> itfhrp  (April & May) 
6. KJNtdpy;fhyk;  - Mdp> Mb (June & July) 
 
tsp Kjypa Fw;wq;fs;> jd;dpiy tsh;r;rp> Ntw;Wepiy tsh;r;rp 
jd;dpiyailAk; fhyk; 
 
Kf;Fw;wk; jd;dpiy 
tsh;r;rp 
Ntw;Wepiy 
tsh;r;rp 
jd;dpiy 
miljy; 
thjk; KJNtdpy; fhh;fhyk; $jph;fhyk; 
gpj;jk; fhh;fhyk; $jph;fhyk; Kd;gdpfhyk; 
fgk; gpd;gdpf;fhyk; ,sNtdpy;  KJNtdpy; 
 
Ropfzj;jpy; Kjypy; gpj;jNjhlk; ghjpg;gile;J jd;dpiy 
tsh;r;rp mile;J gpd;dh; tspFw;wk; Ntw;Wepiy tsh;r;rp mile;J 
mjd;gpd; fgkhdJ jd;dpiy tsh;r;rp mile;J Ropfzj;jpd; 
FwpFzq;fis Njhw;Wtpf;fpd;wJ. 
  
 
 gpj;jk; jd;dpiy tsh;r;rp milAk; fhyk;  -  fhh;fhyk; 
 thjk; Ntw;Wepiy tsh;r;rp milAk; fhyk; - fhh;fhyk; 
fgk; jd;dpiy tsh;r;rp milAk; fhyk;  - gpd;gdpf;fhyk; 
 
vdNt fhh;fhyk; Kjy; gpd;gdpfhyk;> tiuAs;s fhyk; 
Ropfzk; Njhd;Wtjw;Fhpa fhyq;fshFk;  (August to February) 
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Itif epyq;fs;: 
  
  Itif epyq;fisg; gw;wp njhpe;J nfhs;tjpd; %yk; ,d;dpd;d 
epyq;fspy; trpf;f ,d;dpd;d Neha;fs; cz;lhFk; my;yJ ePq;Fk; 
vd;gijAk;> clYf;F ed;ik my;yJ jPikgaf;Fk; epyj;J ePh;fs; 
gw;wpAk; kUe;Jfis rhg;gpLtjw;F kw;Wk; nra;tjw;F rpwg;Gila 
epyk; gw;wpAk; mwpayhk.; 
 
Ie;jpidf; Fzk;: 
 
1.FwpQ;rp 
(kiyepyk;) 
,J Neha;fSf;F ,Ug;gplk;. ,e;epyj;jpy; 
tpisAk; nghUs;fSf;F td;ik cz;lhFk;. 
,uj;jk; cwpQ;Rk; Ruk;> tapw;wpy; Mikf;fl;b 
cz;lhFk;. rpNyl;Lkk; jq;Fk;. 
2. Ky;iy (fhL 
rhh;e;j ,lk;) 
ty;iy Neha;> thj Neha; cz;lhFk;  
3.; kUjk; (tay; 
rhh;e;j ,lk;) 
,e;epyj;jpy; tpisAk; mWRitg; nghUs;fis 
cz;lhy; thjk; Kjypa Kj;Njhl Neha;fis 
xopf;Fk; 
4.nea;jy; (fly; 
rhh;e;j ,lk;) 
nfhLikahd thj Neha; cz;lhFk;. nkype;j 
cliyg; gUf;fr;nra;Ak;. <uiyg; ngUf;Fk;> 
Fly;thAit cz;lhf;Fk;. 
5. ghiy  (kzy; 
rhh;e;j ,lk;) 
thjk;> gpj;jk;> fgk; ,tw;why; tpisfpd;w 
gpzpfl;F ,Ug;gplk;. 
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“gpzpawpKiwik”   -  vz; tifj; Njh;T 
 
 “gpzpawp Kiwik” vd;gJ cliyg; gpzpj;jyha Nehiaj; 
njhe;Jnfhs;Sfpw xOf;fk; vdg;gLk;. 
 
tpjpAk; xOf;fKk;: 
  ,J  
1. nghwpahw;Nwh;jy; 
2. Gydhywpjy; 
3. tpdhjy;  
vd;Dk; tpjpfisAk; mtw;iwj; Jizahfg; gw;wp xOFk; 
xOf;fq;fisAk; Fwpf;Fk;.  Ropfzj;jpy;> Nehahspf;F fhZk; 
FwpFzq;fs;: 
 
1. nghwpahy; mwpjy;: 
  1. %f;F - %f;F ePh; gha;jy; 
 2. eh  - Nfhio Eiujy; 
 3. fz; - rpyNtis fz; rptj;jy; 
 4. Njhy; - rpyNtis mhpg;G> jbg;G fhzy; 
 5. nrtp - rpyNtis fhjpy; rPo; tbjy; 
 
2. Gydhy; mwpjy;: 
 1. ehw;wk; - %f;fpy; rsp rt;T jbg;GWjy; fhuzkhf 
rpyNtis ehw;wkwpa ,ayhik 
 2. Rit - ,dpg;G> rpyNtis Ruk; ,Ue;jhy; ifg;G 
 3. xsp - ,ay;G 
 4. CW - ntg;gk; 
 5. Xir - ,ay;G 
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tpdhjy;: 
 tpdhjy; vd;gJ Nfl;lwpjy; kUj;Jtd; jd;id Nehf;fp te;j 
gpzpAw;wtidg;gw;wp mwpa Ntz;batw;iw mwpe;Jk;> jd; nghwp 
Gyd;fshy; gpzpahsDila nghwp> Gyd; topaha; czh;tij 
gpzpAw;wtdplj;jpNyh my;yJ mtd; ngw;Nwhh; Rw;wj;jhiuf; 
nfhz;Nlh> mtdJ ngah;> taJ> jpiz> FLk;g tuyhW> czT 
gof;ftof;fk;> Ke;ija Nehapd; tuyhW> xt;thik tuyhW 
Nghd;wtw;iw mwpjiyg; gw;wpaJ MFk;. 
 
vz;tifj; Njh;Tfs;: 
 gpzpia mwpAk; top> kUj;Jt E}y; ty;Nyhh;fshy; vz; 
tifaha; tFf;fg;gl;Ls;sJ. 
 ‘ehbg;ghprk; ehepwk; nkhoptpop 
  kyk; %j;jpukpit kUj;JtuhAjk;” 
 
vz;tifj; Njh;Tfshtd 
 eh 
 epwk; 
 nkhop 
 tpop 
kyk; 
%jjpuk; 
];ghprk; 
ehb 
 
Ropfzj;jpy;  - vz;tifj;Njh;Tfspd; epiy 
eh: 
 ,jpy; Ruf;Fk; vr;rpy;> epwk;> thapd; topaha; ntspg;gLk; 
Nfhioapd; epwk;> fdk;> Ngr;rpd; jd;ik ,tw;iw ftdpf;f 
Ntz;Lk;. 
 Ropfzj;jpy; - Nfhio kQ;rs; my;yJ gr;ir kQ;rs; epwj;jpy; 
fhzg;gLk;. 
 Ngr;rpd; jd;ik jho;e;j Fuy; xypAld; fhzg;GLk;. 
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epwk;: 
 Njhy;> cjL> gy;> efk;> eh ,tw;wpd; epwk; ftdpf;fg;gl 
Ntz;Lk;. 
 Ropfzj;jpy; rpyNtis Njhy;> fz;> eh> efk; ,it ntSj;J 
fhzg;gLk;. 
 
nkhop: 
   
 thj Nehahspf;F rkxypAk; 
 gpj;j Nehahspf;F cah;e;j xypAk; 
 Ia Nehahspf;F ,d;dpir Nghd;w <dj;njhdpAk; ,Uf;Fk; 
 Ropfzj;jpy; %r;Rtpl rpukk; cs;sjhy; Ngr;nrhyp Fd;wpAk;> 
Fuy; xyp jho;e;Jk; ,Uf;Fk;. 
tpop: 
 ,jpy; fhZk; epwk;> xsp> rhWk;gPis> topAk; ePh; ,tw;iw 
ftdpf;f Ntz;Lk; 
 Ropfzj;jpy; rpyNtis fz; rptj;jy; kw;Wk; fz; mhpg;G 
fhzg;gLk; 
kyk;: 
 ,jd; epwk;> Eiu> ,Wfy;> ,sfy; ,tw;iw ftdpf;f Ntz;Lk; 
Ropfzj;jpy; rpyNtis kyf;fl;L fhzg;gLk;. 
 
%j;jpuk;: 
 ,jd; epwk;, vil, kzk;> Eiu> vQ;ry; ,tw;iw ftdpf;f 
Ntz;Lk;. 
 Ropfzj;jpy %j;jpukhdJ ntz;ik fye;j kQ;rs; 
epwj;JlDk; EiuAlDk; fhzg;gLk;. 
 
];ghprk;: 
 thj Nehahspf;F cly; rpwpJ ntg;gkha; ,Uf;Fk;. 
 gpj;j gpzpahsh;f;F cly; kpF ntg;gkhapUf;Fk;. 
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 Ia Nehapdh;f;F cly; jl;gkhapUf;Fk;. md;wpAk; tpah;it 
tpLtJkhapUf;Fk;. 
 Ropfzj;jpy; rpyNtis Ruk; ,Ue;jhy; kpF ntg;gkhfTk;> gpw 
Neuq;fspy; jl;gkhfTk; tpah;it tpLtJkhapUf;Fk.; 
 
ehb 
ce;jpjidg; gw;wp aPuysTk; Gz;zha; 
  xUf;fhNy Rthre;jh Dz;lh kpf;f 
 te;jRuk; Grpdhw; NghNy fha;e;J 
  tUj;jkha;j; jpl;L Kl;lha; kaf;fq; fhZk; 
 ,e;j tif fzf;fha;r;r nyd;Nw ehSk; 
  ,ak;Gthh; Gtp kPJ E}y;ty; Nyhh;fs; 
       - ghythflk; 
ce;jpjidg;gw;wp -  gpj;jkhdJ tapw;iwg; gw;wp 
<uysTk; Gz;zha;  - khh;G gFjpia ghjpf;Fk; 
  ,e;Neha; ngUk;ghYk; khe;j Nehapd; njhlh;r;rpahf tUfpd;wJ. 
khe;j Nehapy; gpujhdkhf ghjpf;fg;gLk; cWg;G tapW> gpj;jj;jpd; 
,Ug;gplk; MFk;. gpj;jk; jd; ,ay;gpypUe;J khWgl;L Ntw;Wepiy 
tsh;r;rp mile;J fgj;jpidAk; fgjjpd; ,Ug;gplkhd khh;igAk; 
ghjpj;J IakhdJ %r;R cWg;Gfspd; cs;splq;fspy; milj;J 
nfhz;L fhw;iw ,aw;ifahfr; nry;y nthl;lhkw; jLj;J> Ropj;J 
thq;f nra;fpwJ. 
 
vdpDk; ,f;fl;Liuahsh; Kad;W ghh;j;j tplj;jpy; gpj;jk;;> fgk; 
jd;dpiy tsh;r;rpAw;Wk; thjk; Ntw;Wepiy tsh;r;rp mile;Jk;> 
fPo;f;fz;l ehbeilahdJ ghpNrhjpj;J czug;gl;lJ. 
1. thj gpj;jk; 
2. thj fgk; 
3. gpj;j fgk; 
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1. thjgpj;j ehb: 
  “nghUshd thjj;jpy; gpj;jQ; Nrh;e;J 
  nghUe;J Fzq;fsh K\;zthA Rj;jp 
 nrhpahik Gspj;Njg;gk; nghUky; ePhpw; 
  rptg;Gkyk; gpbj;jYUe; jhJ el;lk; 
 fUthd Njfkjp Yisr;ry; Nrhk;gy; 
  iffhy; jwpg;Gehf; frf;F kd;dk; 
 ghpthd Cz;Fiwjy; UrpNf lhjy; 
  gyNehAk; tUj;jpitf;Fk; ghq;F jhNd” 
      - (rjf ehb) 
2. thjfg ehb: 
“ghq;fhd thjj;jpy; Nrj;Jk ehbg; 
  ghprpj;jhy; jpkph;NkT Kisr;r yhFk; 
 jPq;fhd ,UkYld; re;ep Njhlk; 
  Nrh;e;jtplk; ntbR+iy ,Uj; Nuhfk; 
 thq;fhj <iske; jhu fhrk; 
  typAlNd GwtPr;R cs;tPr;R tPf;fk; 
 Xq;fhZQ; RuKlNd Rthrfhrk; 
  cz;lhFk; ntFNeha;f;F KWjp jhNd” 
       - rjfehb 
gpj;j fgehb: 
  “gz;ghd gpj;jj;jpy; Nrj;Jk ehb 
  ghprpj;jh yj;jpRu kpisg;G <is...” 
       - rjfehb 
ePh;f;Fwp: 
  “te;j ePh; fhpnail kzk; Eiu vQ;rnyd; 
 iwe;jpaYstit aiwFJ KiwNa” 
- Neha; ehly; Kjy; ghfk; 
 
    ePhpy; epwk;>  kzk;> Eiu>  vil>  vQ;ry; Mfpatw;iw Nehf;f 
Ntz;Lk;. 
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nea;f;Fwp: 
  Foe;ijfspd; ehbeil rhpahf fzpg;gjpy; rpukk; cs;sjhy;> 
nea;f;Fwp ghpNrhjid %yk; Nehahsh; vf;Fw;wj;jhy; 
ghjpf;fg;gl;Ls;shh; vd;gjid fzpf;fyhk;. 
 fzNehahspapd; rpWePiu Nrhjid tl;bypy; Cw;wp> R+hpa xsp 
kpFe;j ,lj;jpy; ePhpd; miyapy;yhjNghJ ey;nyz;nza;j;Jsp tpl;L 
ghh;f;fg;gl;lJ. 
  rpyhpy; MopNghy; (Nkhjpuk;) gutpAk; 
 rpyhpy; Kj;JNghy; epd;Wk; fhzg;gl;lJ.  
     NtW rpyhpy; muntd ePz;Lk; fhzg;gl;lJ. 
      ”muntd ePz;bd; thjk; 
       MopNghw; gutpd; gpj;jk; 
       Kj;njhj;J epw;fpd; nkhoptnjd; fgNk” 
 
kUj;Jt topKiwfs;: 
1. Ntw;Wepiy tsh;r;rpaile;j gpj;jj;jpid jd;dpiyg;gLj;j 
Ntz;Lk;. 
2. jd;dpiy tsh;r;rpaile;j Iaj;jpid rkg;gLj;j Ntz;Lk;. 
3. gpj;jf; Fw;wj;jhy; ghjpg;gile;Js;s thjj;jpidAk; rhpg;gLj;j 
Ntz;Lk;. 
4. td;ik ,oe;j clw;fl;Lfis td;ik milar; nra;Ak; 
tifapy; kUe;jspf;f Ntz;Lk;. 
 
With the perspective of bringing out an effective therapy for Suzhi kanam 
from siddha system of medicine, the author has undergone this dissertation 
work with KANAI KIRUTHAM. Since this is a Lipid based medicine it is 
effective and safe for pediatric usage. 
     The dosage of medicine in different age group. 
 3 - 6 yrs   -     5 ml twice daily (before food) 
          7 – 12 yrs     -     10 ml twice daily (before food) 
Physician’s Duty: 
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 Siddha Treatment is not only for complete healing but also for 
prevention and rejuvenation.  Poet Thiruvalluvar says that the duty of 
Physician as follows: 
          “Neha;ehb Neha; Kjy;ehb mJ jzpf;Fk; 
   tha;ehb tha;g;gr; nray;” 
 
    “cw;whd sTk; gpzpasTq; fhyKq; 
    fw;whd; fUjpr; nray;” 
      - jpUf;Fws;. 
 So it is essential for a physician to know the extent of the disease, its 
etiology, the nature of patients, severity of illness, seasons and  time of 
occurrence and exacerbation.  
 
Line of treatment is as follows: 
1. Kaappu (prevention) 
2. Neekkam (Treatment) 
3. Niraivu (Restoration) 
 
1. Kaappu: (prevention) 
   Prevention is the main aim of siddha system.  Siddhars have described 
general preventive measures and special measures. 
 Especially in Balavagadam, special preventive measures that are said 
for prevention of disease of the child starts from the time of conception in  
intra uterine life and also after delivery. 
 The Diet of pregnant women, her habits, Specific medicine to be taken 
in each month of pregnancy, psychological conditions and surroundings 
influence the Prevention of disease in the expected child. 
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2. Neekkam: (Treatment) 
 The aim of treatment is as follows: 
 To bring the vitiated three thoshams into normal equilibrium state. 
 To treat the patients according to the symptoms by internal 
medicine -  Kanai kirutham 
  To educate the Patients about the disease using Flash cards. 
   To teach them simple breathing Exercises which can be followed 
regularly at home. 
 
3. Niraivu: (Restoration) 
 Reassurance of disease recovery was given to all patients. 
 All the patients were advised to have a healthy lifestyle that provides a 
disease free life. 
 Anxiety and general fear about the disease was discouraged by 
educating the patients and their Parents. 
 All the patients were insisted for regular Follow up for the assessment 
of Prognosis which regained their confidence about disease recovery. 
 
i. Diet: 
 Siddhars advise the diet regimens for patients with Kanam.  They are 
explained below. 
 
fiz NehahspfSf;F MFk; fwp tptuk;: 
  “fz;L nfhs;thh; fwp tiff;F tptuk; NfS 
  fjpypAl fhahFk; KUq;ifg; gpQ;R 
 fz;L rpWfPiu neyypf;fha; jhdhFk; 
  jf;f Jtiu mtiuAl gpQ;RkhFk; 
 gz;L nea; ghy; fw;fz;L J}jsq;fha; MFk; 
  ghpthd KaYLk;gpd; ,iwr;rpahFk; 
 nfhz;Lld; nts;shL nts;nsypAk; 
  Fsj;jpYs;s tpuhy; krwpahNk   - kjiyNeha; njhFjp - II 
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tpsf;fk;: 
 thiof;fha; 
 KUq;ifg;gpQ;R 
 rpWfPiu 
 ney;ypf;fha; 
 Jtiu 
 mtiug;gpQ;R 
 J}jsq;fha; 
 nea; 
 ghy; 
 fw;fz;L 
 Kay;,iwr;rp 
 cLk;G ,iwr;rp 
 nts;shL 
 nts;nsyp 
 tpuhy; kPd; 
 krwp kPd; 
 
,it fiz Nehapdh;f;F MFk; czT gjhh;j;jq;fs; 
ii. Pathiyam: 
 During the course of treatment, the patients were advised to follow 
certain restrictions regarding diet and physical activities. 
 This type of medical advice system termed as pathiyam.  Importance 
of pathiyam is said by Theraiyar as follows, 
 
          “gj;jpaj;jpdhNy gyDz;lhFk; kUe;J 
 gj;jpaq;fs; Nghdhy; gyd; NghFk;-gj;jpaj;jpy; 
 gj;jpaNk ntw;wpjUk; gz;bjh;f;F Mjypdhy; 
 gj;jpaNk cj;jpnad;W ghH” 
      - Njiuah; ntz;gh. 
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 The patients with Suzhi kanam were advised to avoid cool beverages, 
and to avoid exposure to chill weather and their specific allergens. 
        
PREVENTION METHODS: 
The patients were advised 
 To findout the allergic causes and to stay away from them or to 
have Protective measures to avoid them. 
 To avoid contaminated food and water 
 To take highly nutritious diet to develop their immunity. 
  Children who are able to under stand and follow the instructions 
are taught simple Yogasanas and preventive measures. 
 
  Pranayama and Yogasanas strengthen the muscles of respiration and 
diaphragm as well as regulate respiration. Hence practising asanas is more 
helpful in asthmatic patients as supportive therapies. 
 
 
The following asanas are helpful in asthma 
 Pranayama 
 Bhujangasanam 
 Chakrasanam 
 Machasanam 
 Mayurasanam 
 Patha hasthasanam 
 Arai machayendhirasanam 
 Trikonasanam 
 Savasanam 
- Sirappu Maruthuvam 
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The following are the simple yogasanas that were taught for the Patients: 
1. Pranayama 
2. Naadi suddhi 
3. Kapala bhati 
4. Bujhangasana 
Pranayama  
This consists of: 
     Poorakam(To breathe in) 
     Kumbakam( To retain air) 
     Rechakam(To breathe out) 
 
Naadi sudhi: 
    This is the fundamental step of Pranayama which is referred to as alternate 
nostril breathing. 
 
Kapalabhathi:  
  The technique of kapalabhati involves short and strong forceful 
exhalations (Rechakam) and inhalation (Poorakam) without kumbakam. This 
facilitates free movement of muscles of stomach as well as those of 
diaphragm. 
All these techniques of Pranayama have been found to increase 
oxygen consumption and alteration in metabolism and autonomic activities 
which are of therapeutic advantage. (Shirlley telles et al., july 15 1993, 
yoga research paper svyasa). Therefore the efficiency of nervous system 
and cardiopulmonary system is increased and has been found to relieve the 
symptoms of Asthma.  
 
Bhujangasana: 
  This asana resembles as serpent posture with raised chest. 
  The benefits of Bhujangasana is it expands the chest, improves blood 
circulation and reduces fatigue and stress. 
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                               MODERN ASPECTS 
 THE RESPIRATORY SYSTEM 
 
Cellular development of lung in-utero: 
        At about 26
th
 week of gestation, the lungs reaches a stage of full 
maturity at which it is capable of supporting life. The rest of the time spent 
in utero from 26 weeks to term is occupied by the development and 
subdivision of the respiratory bronchioles, their saccules and by the growth 
of the airways. 
 
Post-natal development of lungs: 
           At the time of birth there are still no or very few true alveoli, and 
gaseous exchange takes place through saccules or terminal airspaces. The 
alveoli start appearing after birth, first on peripheral saccules and then 
towards proximal respiratory bronchioles and terminal bronchiole. About 
127 million alveoli are present about 1 year and final adult compliment of 
about 280 million have development by 8 years. 
 
Anatomical structure of respiratory tract: 
       The upper respiratory tract is tract is regarded as the part above the 
cricoid cartilage. It has several important functions such as air conduction, 
air conditioning, swallowing, smell and speech. It consists of nose, the 
pharynx, the paranasal sinuses, and larynx. 
      The lower respiratory tract extends from the larynx down to its 
bifurcation in the mediastinum at the level of 5
th
 thoracic vertebrae.The 
trachea divides into right and left main bronchi. The right main bronchus 
being a more direct continuation of trachea is more usual path for inhaled 
foreign bodies to lodge. The right and left main bronchi divides into 
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segmental bronchi and bronchioles. Subsequent divisions contain increasing 
number of alveoli their walls and are called respiratory bronchioles. These 
give off the alveolar ducts and the air sacs and alveoli.  
All these structures are liable to be infected by respiratory tract infections 
and allergy.   
 
Anatomical peculiarities of respiratory tract in children: 
 
 Short thorax with the ribs running more horizontally.  
 Chest wall is thin, elastic and yielding and the intrinsic muscles 
are weak.  
 Increase in antero posterior diameter of the chest with limited 
inspiration.  
 Epiglottis is longer and projects backwards at a greater degree 
than in older Children. 
 All these peculiarities tend to increase the risk of permanent 
deformity in the chest wall in the presence of recurrent or 
longstanding respiratory distress. 
 By above 8 years the chest assumes conical shape since the 
anteroposterior diameter is less than the transverse diameter and 
the ribs are placed in a slightly downward direction.  
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                   ANATOMY OF RESPIRATORY SYSTEM 
 
 
 
         
 
            
 
 
                                            PATHOLOGICAL    CHANGES    
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CHILDHOOD ASTHMA 
Definition: 
Bronchial Asthma is characterised by increased responsiveness of 
tracheobronchial tree to a variety of stimuli resulting in widespread 
narrowing of air spaces. 
 
Etiology: 
The cause of Childhood Asthma is a combination of inherent 
biological and genetic vulnerabilities. 
 
Genetic predisposition: 
Genetic factors play a contributing role in the pathogenesis of asthma. 
Molecular genetic linkage studies indicate that the ‘Atopic’ gene locus is on 
chromosome 11 and the genes for cytokines that are important components 
in the pathogenesis of asthma are encoded in chromosome 5. The allergic 
cytokines are IL 3, 4, 5,9,13 and granulocyte macrophage colony stimulating 
factor. All these are linked to the inheritance of an increased IgE response 
and increased bronchial hyper responsiveness. 
 
Environmental Factors: 
 Common respiratory viruses(Respiratory syncytial virus, rhinovirus, 
influenza, parainfluenza etc) 
 Inhaled allergens 
 Chemical and biological air pollutants 
 Emotional stress 
 Exercise 
 Weather change 
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Magnitude of the Problem: 
Based on the information collected by the national centre for Health 
statistics for disease control and prevention, in 2002, 8.9 million children had 
been diagnosed with asthma in their lifetime. Boys (14%) and girls (10%) 
(Nelson, 2008). 
      The international study of asthma and allergies in childhood (ISAAC) 
reported a prevalence of breathing difficulty in 9% of children from rural 
areas of Tamil nadu.  
India has an estimated 15 -20 million asthmatics with a prevalence of 
10% -15% in 5 to 11 year old children. 
 
Path physiology: 
     The main features of asthma are  
 Airway Obstruction 
 Airway inflammation  and hyper responsiveness 
 
Airway obstruction in asthma is caused by 
- Edema and inflammation of mucous membrane lining the airways. 
- Excessive secretion of mucus, inflammatory cells and cellular debris. 
- Spasm of smooth muscles of bronchi 
 
Inhalation of allergen leads to two distinct phases  
- Early phase 
- Late phase 
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Allergic reaction in a genetically proned allergic reaction in a 
genetically proned individual: 
                                      Allergens (Proteins) 
   
Broken down to peptides and presented on surface of antigen presenting 
cells 
 
Recognised by T-Lymphocytes 
 
Transformed into activated Th2 Lymphocytes and communicates with B 
lymphocytes 
 
Produces mediators, Cytokines, interleukins, and B Lymphocytes produce 
antibodies. 
 
Stimulates B Lymphocytes to produce IgE 
 
IgE molecule attaches to mast cell surface through specific IgE Receptors 
 
Early phase: (15 -30 min) 
       Re-exposure to antigen causes Cross linking of these bound IgE 
molecules by allergen which leads to degranulation of mast cells and release 
of mediators (Histamine, Leukotreins, prostaglandins, Platelet activating 
factor, Bradykinin) 
 
Effect of early phase: 
 Bronchoconstriction 
 Mucosal edema 
 Mucus secretion 
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Late phase 
  Again there is release of mediators. This phase presents as clinical 
asthma. 
 Histamine causes itching, sneezing, and broncho constriction. 
 Prostaglandin causes vasodilatation and vascular permeability 
predisposing to nasal congestion. 
 Leukotriens are potent broncho constrictors 
 
Hallmark of late phase reaction: 
 Infilteration of inflammatory cells, Eosinophils, basophils,            
lymphocytes and macrophages. These substances are responsible for airway 
inflammation and hyper responsiveness. Small airway obstruction due to the 
above mentioned factors causes increase airway resistance which is mainly 
responsible for prolonged expiration and wheezing. Airway resistance is 
increased more during expiration because airways close prematurely during 
expiration.  
As a result lungs are hyper inflated, elasticity and frequency depended 
compliance of the lungs are reduced. Breathing involves more work resulting 
in dyspnoea. Perfusion of inadequately ventilated lungs causes low PaO2. 
In Early stages of illness PaCo2 also falls because of hyperventilation 
caused by dyspnoea. Hyperventilation supervenes resulting in retention of 
Co 2 with a rise of PaCo2. With the exhaustion of buffer mechanisms, PH of 
blood falls resulting in respiratory academia. 
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Bronchial hyper responsiveness and asthma: 
   Bronchial hyper responsiveness is attributed to one or more of the 
following abnormalities 
 Defect in the airway 
 Abnormal neural control of airways 
 Bronchial inflammation 
 
CLASSIFICATION OF ASTHMA 
 
Extrinsic asthma (atopic): 
       Nearly 90% of childhood asthma is extrinsic asthma which is allergic 
asthma. It is often associated with a personal and / or family history of 
allergic diseases such as rhinitis, urticaria and eczema. Positive Wheal and 
flare skin reactions to intradermal injections of extracts of antigens and 
increased levels of IgE in serum. 
 
Intrinsic asthma (non-atopic): 
    A Significant segment of asthmatic population will present with 
negative family or personal history of allergy, negative skin test. They have 
normal serum levels of IgE. Therefore cannot be classified on the basis of 
defined immunologic mechanisms. 
Many of these will develop a typical symptom complex upon 
contracting an upper respiratory illness, after several days the patient begins 
to develop paroxysms of wheezing and dyspnoea that can last for days to 
months. 
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CLINICAL MANIFESTATIONS: 
  
Cardinal sign: 
  The presence of usually diffuse, polyphonic, bilateral and particularly 
expiratory wheeze is the cardinal sign of Asthma. 
 
Most common symptoms: 
 Intermittent dry cough 
 Expiratory wheeze 
 Shortness of breath 
 Chest tightness 
 Intermittent non-focal chest pain 
 Nocturnal cough 
 Dyspnoea 
 Limitation of daily physical activity 
 General fatigue 
 
Associated symptoms: 
 Allergic rhinitis 
 Sneezing 
 Itching 
 Nasal  Congestion 
 Gastro esophageal reflux 
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Symptoms of severe persistent asthma: 
 
    Acute severe attacks on asthma represent the progression of an attack 
of broncho spasm to the point where the patient is breathless at rest and has 
the signs of cardiac stress. They may be extremely sudden onset, but more 
commonly build up over several hours or days. 
 
The following are the symptoms of severe persistent asthma: 
 Increasing breathlessness 
 Difficulty in talking 
 Anxiety to the stage of panic 
 Feeble Breath sounds 
 Absence of Wheeze(Silent chest) 
 Profuse sweating, Restlessness 
 Fatigue 
 Respiratory distress 
 Cardiac arrhythmias 
 Pulsus paradoxus 
 Cyanosis 
 Visible overinflated chest (Barrel shaped) 
 Difficulty in feeding 
 Inability to talk in words or sentences 
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Diagnosis 
     The diagnosis of asthma is a clinical one. Hence detailed clinical 
history taking, physical examination and additional information’s regarding 
family history of Atopy, allergic exposures, circadian variations and seasonal 
exacerbations should be carefully considered. 
 
Differential diagnosis 
 
Bronchiolitis: 
      Bronchiolitis always occurs within the first 2 years usually within 
first 6 months of life. Generally there is a single attack. Repeated attacks 
indicate asthma. Hyperinflation of chest with scattered areas of infiltration 
may be seen in chest X-ray. 
 
Aspiration of foreign body: 
   Unilateral wheezing after an episode of coughing and choking in a 
small child without a history of previous respiratory illness.  
 
Hypersensitivity pneumonitis: 
    This may be observed following inhalation of organic dust, bird 
droppings or exposure to certain chemicals. In the acute form of illness, 
these children suffer from fever, chills, dyspnoea, malaise, aches and pain, 
loud inspiratory rales at the bases of lung and weight loss. X-ray chest shows 
prominent bronchial markings. Levels of IgE antibodies are increased with 
positive skin test. 
 
Vocal cord dysfunction: 
  Intermittent day time wheezing producing shortness of breath, 
coughing. Throat tightness and often audible laryngeal wheeze or stridor. 
This does not respond to Asthma therapy. 
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MATERIALS AND METHODS 
  The study on clinical evaluation of the disease suzhi kanam 
with the trial drug kanai kirutham was carried out in postgraduate 
Kuzhanthai Maruthuvam Department at Government Siddha Medical 
College, Palayamkottai. 20 patients of both male and female children were 
selected for the studies and admitted in postgraduate Kuzhnthai Marthuvam 
In patients ward for 7 days and advised for further follow up as out -patients. 
Another 30 patients are treated with trial drug in the out-patients ward.  
 
SELECTION OF PATIENTS:- 
 The present study covers both male and female children of paediatric 
age groups. All cases were carefully and thoroughly examined before 
admission. Those who fulfilled the criteria of suzhi kanam according to the 
clinical features in siddha and modern reviews were selected with the aid of 
questionnaire. The opinion of professor and lecturer was obtained and 
detailed History was recorded in the proforma of case sheet.  
 
STUDY PARTICIPANTS  
Inclusion criteria 
 Age : 3 – 12 years  
 Sex – Both male and female children 
 Cough with or without expectoration 
 Wheezing of respiratory origin 
 Tightness of chest 
 Shortness of Breath  
 Rhinitis 
 Mild fever 
 Loss of appetite 
 Abdominal bloating 
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 Patients who are willing to stay in IPD for 7 days or willing to attend OP 
Department. 
 Children who are willing to undergo radiological investigation and give 
blood and urine samples for laboratory investigation. 
 Patient’s informant / parent willing to sign the informed consent stating 
that he / she will consciously stick to the treatment during 45 days but can 
opt out of the trial of his / her own conscious discretion.  
 
Exclusion criteria: 
 Children above 12 years and below 3 years. 
 Cough with hemoptysis 
 High grade fever  
 Wheeze other than respiratory cause 
 Congenital heart disease 
 Dyspnoea associated with Cyanosis, clubbing 
 Abdominal distension due to any other serious illness. 
 Sudden reduction of weight 
 Status Asthmaticus.  
 
Withdrawal criteria: 
 
 Occurrence of any adverse reactions. 
 Patients turned unwilling to continue the course of clinical trail. 
 Poor patient compliance. 
 
STUDY OF CLINICAL DIAGNOSIS 
A case sheet was prepared on the basis of siddha and modern 
methodology to diagnose the disease and individual case sheet is maintained 
for each patient.  
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 Siddha diagnostic tools:- 
 Poriyal arithal 
 Pulanal arithal 
 Vinaathal 
 Envagai Thervugal 
 Mukkutram 
 Ezhu Udal Kattugal 
 Thinaigal 
 Paruvakaalangal. 
 
Laboratory investigations 
 
  Blood Urine   Motion 
  TC  Albumin  Ova 
  DC  Sugar   Cyst 
  ESR  Deposits   
  Hb 
 
Radiological Examination 
 Chest X – ray – PA view 
  
Specific Investigations  
 Peak expiratory flow 
 Absolute Eosinophil Count 
 Specific IgE 
 Skin Prick Test.  
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Treatment Methodology: 
 The goals of therapy include physical activity, prevention of 
nocturnal cough, Wheezing and Exacerbations of asthma. 
 The trial drug was prepared carefully according to the siddha 
literature and given to all 50 patients twice a day before food and 
the dose is adjusted according to their age. 
 All the patients and their parents were educated about the “Do’s & 
Dont’s”  of  asthma. 
 Patients were taught to practice pranayama, naadi suthi, 
kabalapathi and bhujangasana which are simple to be followed 
regularly to stabilize their health. 
 
Administration of Trial Medicine:- 
 
The trial drug was prepared carefully according to the Siddha 
literature and given to all 50 patients twice a day and the dose is adjusted 
according to their age.  
 
  3-6yrs - 5ml twice daily before food 
  7-12 yrs - 10 ml twice daily before food 
 
Duration of treatment:   45 days 
 
Patients and their Parents were educated through Fash cards about the 
disease, Diet and were also adviced to do Pranayama and Yogasanas for 
better prognosis and quicker recovery. 
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Analysis of Trial Medicine:- 
 
 The pharmacological analysis of trial drug for its Antispasmodic. Anti 
Histamine, Anti inflammatory and antipyretic activity was carried out 
in the pharmacological laboratory.  
 The Biochemical analysis was performed in Biochemical laboratory. 
 The Antimicrobial Study was carried at Malar Diagnostic centre. 
 The Phytochemical analysis of the trial drug was done at SAIF, Indian 
Institute of Technology (IIT) Chennai.  
 Observations made from patients with signs and symptoms of the 
disease and their prognosis were recorded.  
 
Assessment of prognosis:- 
 
 The Assessment of prognosis   includes the review of the following. 
 Cough 
 Wheezing  
 Night awakening due to respiratory distress 
 Limitation of activity 
 School days missed 
 Pulmonary function Test using Peak Expiratory Flow Meter was 
assessed daily both morning and evening for all In- Patients of  of  
5 years and above and those who would co-operate to blow out 
their personal best and the maximum out of three reading is 
recorded in individual chart to assess the Prognosis 
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FLASH CARDS USED IN PATIENT  EDUCATION      
 
TRIGGERS OF ALLERGY IN CHILDREN 
 
POLLEN 
 
PETS 
 
CHEMICALS 
 
COCKROACHES 
 
INDUSTRIAL SMOKE 
 
CIGARETTE SMOKE 
 
DUSTY ENVIRONMENT 
 
  JUNK FOODS & COOL 
FOOD STUFFS 
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Patient Education... 
WHAT HAPPENS INSIDE YOUR BODY IN ASTHMA? 
 
  
 
COMMON  SYMPTOMS  OF ALLERGY 
 
  
RUNNING NOSE & 
SNEEZING 
 
COUGH 
 
FEVER 
 
SKIN RASHES 
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Patient Education... 
DIETARY ADVICE FOR CHILDHOOD ASTHMA 
(ANTIASTHMATIC VITAMINS) 
   
 
 
 
 
 
 
 
 
NATURAL REMEDYS  FOR  ASTHMA 
 
 
ADATHODAI 
 
 
THOOTHUVALAI 
 
 
KARPOORAVALLI 
 
 
THULASI 
 
 
VENGAYAM 
 
 
MANJAL 
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                                                         Patient Education... 
SIMPLE ASANAS FOR ASTHMA 
      
 
3 IMPORTANT FACTORS TO CONTROL ASTHMA 
 PROPER  INTAKE OF MEDICINE AND REGULAR FOLLOW 
UPS. 
 HEALTHY DIET 
 PHYSICAL ACTIVITY  
 
GET WELL SOON…. 
  Thank you... 
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                                                                  RESULTS AND OBSERVATION 
Results were observed with respect to the following criteria and their 
distribution according to 
 
1. Age 
2. Sex 
3. Socio-economic status 
4. Paruvakaalam 
5. Distribution of lands 
6. Mukkutram  a) vatham b) pitham c) kabam 
7. Ezhu udal kattugal 
8. Envagai thervugal 
9. Neikuri 
10. Aetiological factors 
11. Clinical signs and symptoms 
12. Results 
 
For this study 20 In-patients and 30 Out-patients were selected 
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OBSERVATION 
1.Age distribution. (Table no: 1) 
S.No Age 
No. Of cases 
(out of 50) 
Percentage 
(%) 
1 
0-1 year 
Kappu and Chenkeerai 
- - 
2 
1- 3 years 
Varugai, Thalattu, Sappani, Mutham 
10 20 
3 
 
 
4-6 years 
Ambuli, Chitril, Chiruparai, Chiruthervidhal, Paethai 
(female) & Pillai (male) paruvam 
19 38 
4 
7-10 years 
Paethumbai (female) 
Chiruparuvam (Male) 
14 28 
5 
11-12 years 
Mangai (Female), Valibam (Male) 
7 14 
 
 
 
Inference: 
Therefore the above table indicates that children under the age group of 4 yrs 
to 6 yrs (38%) are mostly affected. 
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2.Sex - distribution: (table no: 2) 
 
S.No Sex No. of cases (out of 50) Percentage (%) 
1 Male 27 54 
2 Female 23 46 
  
 
 
 
 
 
Inference: 
Among 50 cases of study 27 were males (54 %) and 23 were females 
(46%). 
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3.Socio-economic status: (table no: 4) 
 
S.No Socio-economic status No. of cases (out of 50) Percentage (%) 
1 Poor 44 88 
2 Middle Class 6 12 
3 Rich - - 
 
 
 
 
. 
 
Inference: 
According to this study 44 cases (88%) belongs to Poor socio 
economic status and 6 cases (12%) belongs to Middle class. 
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4.Distribution of paruva kalangal (table no: 6) 
S.No Paruvakaalam 
No. of cases 
(Out of 50) 
Percentage 
(%) 
1 
Kaar (Aavani, Purattasi) 
(August to September) 
25 50 
2 
Koothir (Ayppasi, Karthigai) 
(October to November) 
15 30 
3 
Munpani (Markazhi, Thai) 
(December to January) 
5 10 
4 
Pinpani (Masi, Pankuni) 
(February, March) 
3 6 
5 
Ela Venil (Chithirai, Vaikasi) 
(April to May) 
1 2 
6 
Muthuvenil (Aani, Aadi) 
(June to July) 
1 2 
 
 
Inference: 
The Table showed the more prevalence of the disease under 
Kaarkaalam – 50%. 
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5.Distribution of lands: (table no: 7) 
S. No Thinai No. of cases (Out of 50) Percentage 
1 Kurinji (hill) 5 10% 
2 Mullai ( forest) - - 
3 Marutham (fertile) 40 80% 
4 Neithal ( coastal) 5 10% 
5 Paalai ( desert) - - 
 
 
 
Inference: 
According to siddha concept, no disease occurs to the people living in 
marutham. Incidence of disease in marutha nilam and neithal nilam were due 
to altered life style and environment. In addition, the study was conducted in 
and around Tirunelveli, a Marutham land. Therefore, majority of the cases is 
from that land. . 
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6.MUKKUTRA THEORY: (Table No: 8) 
a.Derangement of vatham:- 
S.No Types of Vatham 
No. of cases 
(Out of 50) 
Percentage 
1  Pranan  50 100 
2 Abanan  20 40 
3 Viyanan  50- 100 
4 Uthanan  50 100 
5 Samanan  50 100 
6 Naagan  40 80 
7 Koorman - - 
8 Kirukaran  30 60 
9 Devathathan  20 40 
10  Dhananjeyan - - 
 
 
Inference: 
In vatham, all cases had derangement in Pranan, Viyanan, Uthanan, and 
Samanan.  
 
0% 
10% 
20% 
30% 
40% 
50% 
60% 
70% 
80% 
90% 
100% 
 Pranan  Abanan  Viyanan  Uthanan  Samanan  Naagan  Koorman Kirukaran  Devathathan  Dhananjeyan 
100% 
40% 
100% 100% 100% 
80% 
0% 
60% 
40% 
0% 
DERANGEMENT OF  VATHAM 
 79 
b.Derangement of pitham: 
S.No Types of Pitham 
No. of cases 
(out of 50) 
Percentage 
1 Anilam  30 60 
2 Ranjakam  15 30 
3 Saathakam  50 100 
4 Pirasakam  10 20 
5 Aalosakam  - - 
 
 
 
Inference: 
In Pitham, Sathagam was deranged in 100% of cases, 60% had 
derangement of anilam,.30% had derangement of ranjakam and 20%  had 
dreangement of pirasakam. 
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c.Derangement of kabam: 
S.No Types of Kabam 
No. of cases 
(out of 50) 
Percentage (%) 
1    Avalambakam  50 100 
2 Kilethakam  30 60 
3 Pothakam  25 50 
4 Tharpakam  30 60 
5 Santhikam  - - 
 
 
 
 
Inference: 
In kapha avalambagam was deranged in all patients. Kilethagam and 
Tharpakam was deranged in 60%   and pothagam was deranged in 50% 0f 
Children. 
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7. Udal kattugal: (table no: 9) 
S.No Udal kattugal 
No. of cases 
(out of 50) 
Percentage (%) 
1 Saaram  50 100 
2 Senneer  15 30 
3 Oon  20 40 
4 Kozhuppu  20 40 
5 Enbu  - - 
6 Moolai  - - 
7 Sukkilam / Suronitham  
 
- - 
 
 
Inference: 
In Ezhu udal kattukal 100% of the cases had derangement of saaram. 
40% had derangement of Oon and kozhuppu. 30% had derangement of 
seneer.  
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8.Enn vagai thervugal: (table no: 10) 
S.No Enn Vagai Thervugal No. of cases (out of 50) Percentage (%) 
1 Naa  20 40 
2 Niram 5 10 
3 Mozhi  10 20 
4 Vizhi  30- 60 
5 Sparisam  20 40 
 
6 
           Naadi 
 
             
 
 
  
7 Malam  20 40 
8 Moothiram  - - 
 
  
Inference: 
In ennvagai thervugal, Naa and Sparisam were affected in 40% 0f cases. 
60% of cases had Vatha kabham Naadi.   
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9. Nei kuri: 
S.No 
Neikuri 
Reference 
Characters of 
Urine 
No. of cases 
(out of 50) 
Percentage 
(%) 
1 Vatha Neer Spreads like Snake 5 10 
2 Pitha Neer Spreads like Ring 10 20 
3 Kaba Neeri Spreads like Pearl 35 70 
 
 
 
Inference: 
Vatha neer was observed in 10% of the cases. Pitha neer was observed in 
20% of cases and kaba neer was observed in 70% of cases. 
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10.Aetiological factors of suzhi kanam 
S.No Aetiological factors No. of cases 
(Out of 50) 
Percentage 
(%) 
1 Inhaled allergens 40 80 
2 Cool beverages and  Ice creams 40 80 
3 Respiratory infections 25 50 
4 Climatic changes 30 60 
5 Family history of allergic diseases. 35 70 
 
 
 
 
 
 
Inference: 
From the above table it is evident that intake of cold stuff’s, Ice 
creams etc., and inhaled allergens are the main cause of Suzhi kanam. 70% 
of cases have a positive family history of allergic diseases. 
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11.Clinical features - signs and symptoms.  
The signs and symptoms of patients with Suzhi kanam under the 
clinical study was given below. 
S.No Clinical features 
No. of cases 
(Out of 50) 
Percentage 
1. Wheeze 50 100 
2. Nocturnal cough  40 80 
3. Non focal chest pain 15 30 
Associated symptoms 
4. Fever 35 70 
5. Sinusitis 30 60 
6. Allergic rhinitis 30 60 
7. Vomiting 35 70 
 
 
 
 
Inference: 
Major clinical symptoms reported to be Wheeze, Nocturnal cough, vomiting 
and fever.Most of the clinical signs were relieved after treatment.  
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12.Results 
 Among 50 cases, the results were observed as follows. 
S.No Result No. of cases (Out of 50 ) Percentage (%) 
1. Good 40 80 
2. Moderate 7 14 
3. Poor 3 6 
 
 
 
 
Inference: 
80 % (40 cases) showed good results and 14 % showed moderate 
response. 6 % of the cases showed poor response. These results are based on 
the clinical improvement. 
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OUT PATIENTS RECORD 
 
S.NO OP NO NAME AGE / SEX NO OF DAYS 
TREATED 
REMARKS 
1. 1060 Esakkimuthu 11y/MC 45 Good 
2. 13911  Aseela 8y/FC 45 Good 
3. 21423  Lakshan 7y/MC 40 Good 
4. 40558  Jagan 8y/MC 45 Good 
5. 43119 Karpagalakshmi 12y/FC 39 Good 
6. 44099 Deepa 10y/FC 35 Moderate 
7. 46178 Lohitya 3y/FC 41 Good 
8. 52694 Brison 4y/MC 45 Good 
9. 53669 Santhoshkumar 7y/MC 40 Good 
10. 53794 Sriram 5y/MC 43 Good 
11. 53952 Grace 10y/FC 45 Moderate 
12. 55311 Akshitha 3y/FC 40 Good 
13. 55314 Akash 6y/MC 35 Moderate 
14. 55324 Sagithya 3y/FC 43 Good 
15. 55429 Anushya 9y/FC 35 Good 
16. 56277 Mohanraj 4y/MC 48 Good 
17. 58309 Muthukrishnan 4y/MC 45 Good 
18. 58326 Lakshmi 12y/FC 39 Good 
19. 58327 Poornapushpakala 10y/FC 40 Poor 
20. 60730 Varshini 3y/FC 45 Good 
21. 62465 Muthukrishnan 5y/MC 44 Good 
22. 63247 Baskar 3y/MC 43 Good 
23. 63988 Santhanalakshmi 7y/FC 46 Good 
24. 67502 Nandhini 5y/FC 38 Moderate 
25. 67661 Prakash 5y/MC 42 Good 
26. 67785 Jeeneth 4y/FC 40 Good 
27. 71670 Vishal 12y/MC 30 Moderate 
28. 71765 Irshani 8y/FC 45 Good 
29. 71766 Sadhu 5y/MC 30 Poor 
30. 74272 Anishwaran 12y/MC 39 Good 
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CASE SHEET REPORTS – IN PATIENTS 
S.
N 
IP No Name of patient 
Age/  
sex 
Address Signs and symptoms 
Admissio
n date 
Discharg
e date 
No. of days 
Result 
Trea
ted 
in IP 
Follo
w-up 
in OP 
1. 2136 Christopher 3y/MC 261,old 
colony,sankarankoil 
 Nocturnal cough, Wheeze, 
poor appetite,  fever, running 
nose.  
02.07.12 07.07.12 6 40 Good 
2 2195 Arulraj 10y/MC 85,Trichendur road, 
Palay. 
Cough with expectoration, 
difficulty in breathing, 
Wheeze, running nose, Head 
ache. 
06.07.11 16.07.11 10 35 Good 
3 2636 Mariyammal 3y/FC 3,Melatheru, 
Thenkasi 
Cough, wheeze, difficulty in 
breathing. 
09.08.12 
 
14.08.12 
 
6 42 Good 
4 2657 Vishnupriya 12y/FC 1/91,mutaraman 
st,srivaikundam,tvl 
Cough with expectoration, 
Wheeze, difficulty in 
breathing, poor appetite,  
limitation of activity, tiredness, 
11.08.12 16.08.12 6 40 Good 
5 2694 Baskar 3y/MC 2, sivankoil st, 
palay. 
Nocturnal Cough, Wheeze, 
difficulty in breathing, 
Running nose. 
14.08.12 20.08.12 7 30 poor 
6 2807 Babymathunisha 4y/MC 110/8, darling nagar 
,tvl. 
Nocturnal Cough, Wheeze, 
difficulty in breathing. 
24.08.12 01.09.12 9 42 Good 
7 2886 Brison 3y/FC 11,sms comp, 
murugankurichi 
Nocturnal cough, Wheeze, 
poor appetite,  fever, running 
nose 
31.08.12 08.09.12 9 40 Good 
8 3019 Suresh 5y/MC 34, sivankoil st, 
melaveethi, palay 
Cough with expectoration, 
Wheeze, poor appetite, Head 
ache, tiredness, 
11.09.12 17.09.12 7 35 Good 
9 3236 Nandini 5y/FC 8, Krishnankoil st, 
palay. 
Cough, wheeze, difficulty in 
breathing 
26.09.12 29.09.12 4 40 Moderate 
10 3257 Keerthanasri 9y/FC 154, bathrakali koil 
st, Palay. 
Cough with expectoration, 
Wheeze, difficulty in 
breathing, limitation of 
activities. 
26.09.12 29.09.12 4 30 Good 
11 3343 Isakkimuthu 11y/MC 1c/4, 
svk,puthupettai 
Nocturnal Cough, Wheeze, 
difficulty in breathing, running 
nose, Headache, limitation of 
activities, Poor appetite. 
29.09.12 03.10.12 5 40 Good 
12 3354 Vishal 12y/MC 341, 11
th
 cross st, 
gopalanagar, 
tutucorin. 
Nocturnal Cough, wheeze, 
Headache, tiredness, 
30.09.12 3.10.12 4 35 Moderate 
13 3356 Muthukrishnan 5y/MC 51E, Vadakutheru, 
melalingapuram 
Nocturnal Cough, Wheeze, 
difficulty in breathing, 
Running nose. 
30.09.12 03.10.12 4 35 Good 
14 3594 Gomathy 
sankar 
12y/MC 17,sivaraman comp, 
ambedker nager, 
pettai 
Nocturnal cough, Wheeze, 
Poor appetite,  fever, running 
nose. 
16.10.12 21.10.12 6 40 Good 
15 3597 Byas 4y/MC 27
th
 st, santhinagar, 
palay 
Cough, wheeze, difficulty in 
breathing. 
16.10.12 21.10.12 6 40 Good 
16 3601 Iyammal 6y/FC 34/146,sathyanagar, 
puthupet 
 Nocturnal Cough, Wheeze, 
difficulty in breathing, running 
nose, Headache, limitation of 
activities, Poor appetite. 
17.10.12 21.10.12 5 35 Good 
17 3619 Meenakshi 11/MC 6/133,Nadutheru, 
nallammalpuram,tvl 
Cough with expectoration, 
Wheeze, difficulty in 
breathing, poor appetite, 
limitation of activity, tiredness.  
18.10.12 24.10.12 7 38 Good 
18 3419 Kumar 4y /MC 3/87, 
melavarthopu,srivai
kundam,tuticorin 
Nocturnal cough, Wheeze, 
poor appetite, fever, running 
nose. 
04.10.12 08.10.12 5 42 Good 
19 3346 Muhammed 5y/MC 14B,chinatheru, 
melapalayam. 
Nocturnal cough, Wheeze, 
poor appetite,  fever, running 
nose 
29.09.12 03.10.12 5 30 Good 
20 4095 Kaviya 12y/MC N0-3/4, kumaran 
nagar, thuthukoodi. 
Nocturnal Cough, Wheeze, 
difficulty in breathing, running 
nose, Headache, limitation of 
activities, Poor appetite. 
06.12.12 10.12.12 5 35 Good 
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LABORATORY INVESTIGATIONS - HAEMATOLOGICAL PROFILE 
 
 
BT- Before treatment , AT –After treatment ,P – Polymorphs,  L – Lymphocytes, E-Eosionophils,   
ESR – Erythrocyte Sedimentation Rate, Hb -Haemoglobin  
 
 
 
 
 
 
S.No. IP.No 
Name of the 
patient 
Hematological Investigation 
WBC Total 
Count cells 
/  cu.mm 
WBC differential count ESR – mm/ Hr 
Hb gm% 
BT AT BT AT 
BT AT P% L% E% P% L% E% ½ hr 1hr ½ hr 1hr BT AT 
1. 2136 Christopher 8200 8000 65 30 6 67 30 3 7 16 4 8 10.4 10.6 
2. 2195 Arulraj 9400 8750 54 40 5 50 48 2 16 30 10 20 10.2 10.3 
3. 2636 Mariyammal 7600 7300 68 35 7 55 40 4 12 25 5 9 9.3 9.5 
4. 2657 Vishnupriya 9100 8970 56 30 7 59 36 5 13 20 5 10 10.6 10.8 
5. 2694 Baskar 9000 9000 48 34 10 61 60 10 12 22 13 26 10.9 11 
6. 2807 Babymathunisha 8500 8300 65 54 8 65 30 7 10 28 6 12 11.4 11.5 
7. 2886 Brison 8200 8100 55 48 10 52 41 4 16 26 8 12 9.6 9.6 
8. 3019 Suresh 8900 8800 57 40 8 68 26 3 14 29 7 14 8.7 9 
9. 3236 Nandini 8300 8200 66 46 8 60 58 8 15 24 14 20 9.5 9.7 
10. 3257 Keerthanasri 8400 8100 62 32 10 70 24 4 8 15 2 4 11 11.1 
11. 3343 Isakkimuthu 9800 8500 54 38 8 59 34 6 6 18 4 8 10.4 10.5 
12. 3354 Vishal 8000 7900 55 35 5 60 35 7 12 24 10 20 10 10.2 
13. 3354 Vishal 9000 8000 48 45 4 55 42 2 18 36 6 12 10 10.4 
14. 3594 Gomathysankar 8200 8000 54 38 11 61 35 6 13 26 6 12 7.8 8.0 
15. 3597 Byas 7500 7200 52 46 4 58 40 2 12 24 5 14 11.1 11.3 
16. 3601 Iyammal 8700 8000 55 42 3 59 48 3 9 18 4 8 10.4 10.5 
17. 3619 Meenakshi 8300 8000 54 43 3 61 36 3 12 23 1 3 12.1 12.2 
18. 3419 Kumar 7800 7700 60 35 5 64 31 5 5 12 4 6 8.8 9.0 
19. 3346 Muhammed 8900 8900 54 38 8 58 35 7 9 20 4 8 10.1 10.2 
20. 4095 Kaviya 9100 9000 60 31 9 63 30 7 6 14 5 9 11.4 11.4 
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LABORATORY INVESTIGATIONS - URINE, MOTION, MANTOUX TEST 
 
S.No Ip.No 
Urine Analysis Motion Analysis 
Mantoux 
Test 
Before Treatment After Treatment Before Treatment After Treatment 
Alb Sug Dep/ HPF Alb Sug 
Dep / 
HPF 
Ova Cyst 
Occult 
Blood 
Ova 
Cyst 
Occult 
Blood 
1. 1438 - - - - - - - - - - - 
2. 1439 - - 1-2 pc - - - - - - - - 
3. 1729 - - - - - - - - - - - 
4. 1795 - - - - - - - - - - - 
5. 2041 - - 1-2 pc - - - - - - - - 
6. 2198 - - - - - - - - - - - 
7. 2390 - - - - - - - - - - - 
8. 2391 - - - - - - - - - - - 
9. 2392 - - - - - - - - - - - 
10. 2530 - - 2-3 Pc - - - - - - - - 
11. 2620 - - - - - - - - - - - 
12. 2625 - - - - - - - - - - - 
13. 2734 - - - - - - - - - - - 
14. 2765 - - - - - - - - - - - 
15. 2781 - - 1-2Ec - - - - - - - - 
16. 2886 - - 2-3Ec & Pc - - - - - - - - 
17. 2948 - - - - - - - - - - - 
18. 2955 - - - - - - - - - - - 
19. 3061 - - - - - - - - - - - 
20. 3108 - - - - - - - - - - - 
 
 
PC- Pus cells   HPF – High Power Field   EC – Epithelial 
Cells 
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ASSESMENT OF PROGNOSIS BY  
PEAK EXPIRATORY FLOW RATE (PEFR)  
 
S.NO IP.NO NAME AGE/ 
SEX 
HEIGHT 
(CM) 
PEFR 
EXP BT AT 
1 2687 Vishnu priya 12y/F 131 250 60 200 
2 2195 Arul raj 10y/M 122 200 80 170 
3 3236 Nandini 5y/F 104 100 60 90 
4 3257 Keerthana sri 9y/F 121 200 100 150 
5 3345 Isakki muthu 11y/M 133 250 80 220 
6 3277 Sakthi balaji 8y/M 112 150 90 120 
7 3354 Vishal 12y/M 130 250 80 150 
8 3594 Gomathi Sankar 12y/M 131 250 80 230 
9 3356 Muthu Krishnan 5y/M 102 200 100 200 
10 3601 Iyammal 6y/F 100 100 60 100 
11 3619 Meenakshi 11y/F 133 250 80 210 
12 4095 Kaviya 8y/M 110 150 60 120 
13 3419 Kumar 4y/M 103 110 80 130 
14` 3019 Suresh 5y/M 101 200 100 200 
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TREATMENT AND PROGNOSIS 
 
IN-PATIENTS  PRACTISING  PRANAYAMA 
 
                 
 
PROGONOSIS 
 
              
       BEFORE TREATMENT                AFTER TREATMENT 
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DISCUSSION 
Suzhi Kanam is a paediatric problem, the clinical features of which are 
clearly described in various Sridhar texts. This disease most probably correlates 
with Childhood Asthma which limits the daily activities of child and interferes 
with sleep and school absenteeism.   
    
  In this study 30 cases were treated at the Out-Patient post graduate 
department and 20 cases were treated at the In-Patient ward.   Siddha methods 
of diagnosis were carried out and recorded in the selection proforma, and the 
diagnosis was confirmed with the help of modern investigations. The Patients 
were treated with drug KANAI KIRUTHAM and clearly observed.  The 
observations are discussed here under. 
 
1. Distribution according to Age: 
 This study indicates that children’s under the age group of 4 to 6 years 
(38%) are mostly affected since they contribute to school going age they may be 
newly exposed to a variety of allergens. 
 
2. Distribution according to sex: 
 Among 50 cases of study 54% were male children and 46% were female 
children. 
 
3. Distribution according to socio economic status: 
 Most of the Patients (88%) belonged to poor socio economic status. 12% 
of the cases were middle class. Due to Poverty, malnutrition, Overcrowding, 
and unhygienic practices this disease is more prevalent among the poor. 
4. Distribution of paruva kaalangal: 
 According to Paruvakaalam the highest Distribution (50%) was noted in 
Kaarkaalam. 
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5. Distribition of lands: 
         Among the selected 50 cases 80% of them were from Marutham land and 
10% of them were from Kurinji and Neithal. This is due to the fact that the 
study was conducted at Tirunelveli, a Marutham land and so majority of the 
cases were from that land.  
 
6. Distribution according to Uyir thathukkal: 
 
i. Derangement of Vatham: 
 Due to derangement of Vatham, the following symptoms may occur. 
Pranan (100%) causes difficulty in breathing and wheezing. Abanan (40%) 
causes constipation in some patients. Viyanan (100%) causes emaciation, 
uthanan (100%) causes cough and sneezing, Samanan (100%) causes loss of 
appetite, Naagan was deranged in (80%) of cases as some patients had difficulty 
in Playing and other activities.   
 
ii. Derangement of Pitham: 
 Analpitham was deranged in 60% of patients causing indigestion and 
abdominal bloating, Ranjakam was deranged in 30% of patients due to 
malnutrition, saadhagam was deranged in 100% of patients causing limitations 
in their daily physical activities, and pirasagam was deranged in 20% of cases 
who were presented with allergic manifestation of skin. 
 
iii. Derangement of Kabam: 
 Due to derangement of Kabam, avalambagamvwas deranged in 100% of 
patients, kilethagam was deranged in 60% of patients causing poor apetite, and 
constipation. Pothagam was deranged in 50% of patients. 
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7. Distribution according to Ezhu Udar kattugal: 
 In ezhu udar kattugal, saaram (100%), Seneer (30%), Oon (40%), 
Kozhuppu (40%) were affected causing general fatigue, malaise and emaciation.  
 
8. Enn vagai thervugal: 
 According to this study, naa was affected in 40% of cases (Coated and 
pallor), Sparisam was affected in 40% of cases (fever), Niram was altered in 
10% of patients due to anemia, Mozhi was affected in 20% of patients due to 
breathing difficulty, vizhi was affected in (60%) of patients causing Redness 
(Allergic symptom of eyes), Malam was altered in 40% of patients 
(constipation). 
 
9. Neikuri: 
   In this study most of the patients had kaba neer (70%) which stood as a Pearl 
indicating that the most predominant manifestation of this disease is kabam. 
 
10. Distribution according to Aetiological factors: 
 Inhaled Allergens, cool foods and beverages contribute to 80% of the most 
common Etiological factors. Family history of allergy was found in 70% of the 
cases. 60% of cases were affected by Climatic changes. 50% of cases were with 
Etiology of Respiratory infection.  
 
11. Distribution of clinical features: 
    Almost all cases were presented with Wheeze and nocturnal cough. 70% of 
cases had fever and vomiting. 60% of cases were presented with sinusitis and 
Allergic rhinitis.  
 
12. Lab Investigation: 
  Routine examinations of blood, Urine and Motion were done during 
admission and discharged. In most of the cases ESR and total leucocyte count 
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was elevated before treatment .Mantoux test was done for differential diagnosis 
to exclude Primary complex. 
 
13. Biochemical analysis: 
       Qualitative analysis of the trial drug revealed the Presence of Ferrous iron 
which is more soluble and readily absorbable form that helps in treating 
children who are associated with Anemia. The study also indicates the presence 
of Chloride, reducing sugar and unsaturated compounds.  
 
14. Antimicrobial activity: 
    Antimicrobial activity of Kanai Kirutham showed that it inhibited the growth 
of bacterial strains of Streptococcus pneumonia and Staphylococcus aureus. 
 
14. Pharmacological analysis: 
        Pharmacological Analysis showed the drug has significant 
antiinflammatory action and also has Antipyretic, Antispasmodic, and 
Antihistamine Action. 
 
15. Phytochemical analysis: 
        The Preliminary GC Analysis of aqueous extract of Kanai Kirutham 
showed the Presence of Phytochemicals such as Alkaloids, Saponins, 
Glycosides, Carbohydrates and Triterpenoids. 
 
16. Selection of the Trial Drug: 
  The selection of trial drug is based on the Pharmacological action of drug, 
both in Siddha and Modern aspect. 
 
Pharmacodynamic action of kanai kirutham (siddha aspect): 
 
  The pharmacodynamic action of kanai kirutham is based on its ability to 
pacify the vitated three humours.  
This is explained as follows.... 
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fiz fpUjj;jpd; rpwg;G: 
   
 NrUk; ruf;Ffs; Rit jd;ik gphpT 
1. J}Jtis rpWifg;G> 
fhh;g;G 
ntg;gk; fhh;g;G 
2. rpWfPiuNth; ,dpg;G jl;gk; ,dpg;G 
3. jz;zPh;tpl;lhd; fpoq;F ,dpg;G jl;gk;  ,dpg;G 
4. mjpkJuk;  ,dpg;G jl;gk; ,dpg;G 
5. ntq;fhak;  ifg;G ntg;gk; fhh;;g;G 
 
tpsf;fk;: 
  gpzp ePf;fj;jd; nghUl;L nra;Ak; kUe;Jfs; ahTk; jj;jk; Rit> 
Fz tPhpaq;fshy; Neha;fisj; jPh;f;Fk;. 
  cz;Zk; czthdJ cl;nrd;w gpd; mt;tg;gjhh;jjq;fspy; 
mlq;fpa Ritfs; rluhf;fpdpapd; rf;jpahy; tpghfk; (gphpT) mile;J 
,dpg;G> Gspg;G> fhh;g;G vd;Dk; gphpTfis milfpwJ. 
  mt;thW gphptilAk;NghJ> fiz fpUjkhdJ ,dpg;G kw;Wk; 
fhh;g;G gphpTfis milfpwJ. 
,dpg;G: 
 jd;dpiy tsh;r;rp mile;j thjj;ijAk;;> gpj;jj;ijAk; 
rkg;gLj;Jk;. 
 ,jid jf;f msTld; cl;nfhs;spd; clw;fl;LfSf;F td;ik> 
cly; xsp> Cl;lk; mspf;Fk;. 
 ghyh; Kjy; tpUj;jh; tiu fhrNehahy; tUe;Jgth;fSf;F Rfk; 
mspf;Fk;. 
 ; njhz;il Njhlq;fisg; Nghf;Fk;. 
 
fhh;g;G: 
 fgj;ij rkg;gLj;Jk; 
 njhz;ilg;gpzp> Nrhif> eikg;gil Nghf;Fk;. 
 tapw;wpy; fgj;jhy; cz;lhFk; Jh;ePiu twl;Lk; 
 nfl;l kyj;ij fopg;gpf;Fk; 
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Therapeutic uses of ingredients in Kanai Kirutham (Modern Aspect): 
 
 Solanum trilobatum has antiinflammatory, antiasthmatic 
immunomodulatory effect. 
 Amaranthus tricolor is nutritive, laxative and has antiallergic properties. 
 Asparagus racemosus is nutritive, antispasmodic antitussive, expectorant 
and is used in fever constipation. 
 Glycyrrhiza glabra has antiarthmatic and antibacterial property. 
 Allium cepa is nutritive and anti-asthmatic. It relieves pediatric cough,  
flatulence and skin allergy. 
 Cow’s ghee is used as a base to transfer the fat soluble active principles 
of the drug in it. It is nutritive and strengthens the immunosystem. 
 
Therefore the properties of the ingredients of Kanai Kirutham based on 
its “ Suvai” and its therapeutic uses has prompted the author to select this drug, 
for the treatment of Suzhi kanam. 
 
17.Result: 
       Satisfactory improvement was reported in 4 days of commencement of 
treatment. Out of 50 cases 40 Patients (80%) showed Good response with 
remarkable relief of symptoms, frequency of similar episodes and improvement 
in school attendance. Moderate result was observed in 7 cases (14%) with 
reduction of signs and symptoms. In 3 cases the result was poor (6%), as there 
was no significant improvement of Symptoms. 
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SUMMARY 
 The Aim of this dissertation subject is to assess the efficacy of trial drug 
‘Kanai Kirutham’ for ‘Suzhi Kanam’ without any adverse effects.  
 
 The Etiopathogenesis and symptoms of Suzhi Kanam have been correlated 
with that of childhood Asthma with evidences of literature.  
 
 Clinical diagnosis and selection of cases was based on clinical features 
described in Balavagadam Text book and also using questionnaire.  
 
 The Medicine Chosen for Treatment and management of Suzhi Kanam was 
Kanai Kirutham 5 to 10 ml (according to age) internally, twice a day, before 
food.   
 
 The Trial drug selection is based on its siddha pharmacological action to 
pacify the deranged vatham, pitham and kabam and also due to its 
Immunomodulatory and anti-asthmatic effect of ingredients.  
 
 Fifty Children (20 In-patients and 30 Out-patients) were diagnosed with 
Suzhi Kanam clinically and they were observed for clinical diagnosis, 
laboratory diagnosis, Peak expiratory flow rate during the treatment and the 
results were dealt in the Proforma. 
 
 The treatment covers Administration of trial drug according to the age and 
also includes simple Asanas, educating the patients and their parents about 
childhood asthma and its management, adherence to treatment and dispel 
fear and misconceptions.  
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 The documentation of observations made during the clinical study showed 
that the drug is clinically effective.  
 The Preliminary GC Analysis of aqueous extract of Kanai Kirutham showed 
the Presence of Phytochemicals such as Alkaloids, Saponins, Glycosides, 
Carbohydrates and Triterpenoids. 
 
 In Biochemical analysis the trial medicine had Ferrous iron which adds to 
the clinical prognosis of Suzhi kanam by Kanai kirutham. 
 
 Antimicrobial activities of Kanai kirutham showed that it inhibited the 
Growth of Bacterial strains against Streptococcus pneumoniae and 
Staphylococcus aureus. 
 
 In the Pharmacological analysis, the trial drug Kanai kirutham had 
significant Acute anti-inflammatory action, and also had Anti-pyretic, Anti-
spasmodic, Anti-Histamine action which by the virtue of controlling the 
airway inflammation help to improve the Patients quality of life 
 
With these benefits Kanai Kirutham can be deemed as an effective Drug for 
Suzhikanam (Childhood asthma). 
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CONCLUSION 
 The Global burden of Respiratory Allergies in children, increasing 
prevalence and its impact in reducing the quality of life in children has 
prompted the author to choose an efficient and nutritive drug which is believed 
to influence the Immune System.  
 
 The treatment of suzhi kanam with kanai kirutham has showed good 
response with no adverse effect and ensures to be safe, effective and simple to 
administer. 
 
 Therefore it is concluded that the trial drug “kanai kirutham” along with 
the modalities of Pranayama, Yogasanas and patient education will benefit the 
society and meet patient’s and family’s expectations of satisfactory Asthma care 
in children.  
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ANNEXURES 
ANNEXURE I 
DRUG REVIEW - PREPARATION AND PROPERTIES OF TRIAL DRUG 
Name of the Medicine - fizf; fpUjk; 
Reference            - mfj;jpah; itj;jpag; gps;isj; jkpo; - gf;fk; 27 
 
fizf; fpUjk; :  
 J}Jsq; fha;gok; NtUkpiy G+tpndhL 
  nrhw;rpWf; fPiu %ye; 
 NjhakJ tpl;lhd; fpoq;fpndhU kJuKe; 
  JbaPu Ts;spA nkyhk; 
 ePjKw Nttif fsQ;Reh yhtpnda; 
  Ner. nkhLfhw; gbapdpy; 
 NeHj;jpAl Ndrptf; ff;fha;r;R fhnrilnea; 
  ePaUe; jf;nfhLf; fr; 
 Nrjg; gLj;jtU fiz gpusp Njh\KQ;  
  nra;twl; Nrhif apUky; 
 jpl;LKl; nld;WtUq; fhrq; fgq;fSe; 
  jpUFj; jpUky; tha;TQ; 
 rhwhJ NghnkDk; nghjpifkiy ahjpg 
  rg;ghzp nfhl;b aUNs  
 rq;fuw; fpdpjhd jtKa ufj;jPr 
  rg;ghzp nfhl;b aUNs. 
 
Njitahd ruf;Ffs; (Ingredients) 
1. J}Jtis r%yk; (Solanum trilobtum)  -  21 gms 
2. rpWfPiuNth; (Amaranthus tricolor)   - 21 gms  
3. jz;zPh;tpl;lhd; fpoq;F (Asparagus racemosus) -  21 gms 
4. ntq;fhak; (Allium Cepa)    - 21 gms 
5. mjpkJuk; (Glycyrrhiza glabra)    - 21 gms  
6. gR nea; (Cows ghee)     - 325 ml 
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nra;Kiw: 
  ruf;Ffisnay;yhk; xd;wha;r; Nrh;j;J ntz;nza; Nghy 
miuj;J fhyzhg; gpukhzk; rpWtpy;iyfshfj;jl;b nea;apypl;L 
mLg;Ngw;wpr; rpWjPahnahpj;J tpy;iyfs; nghd;dpwkhfr; rpte;j 
gf;Ftkha;f; fha;r;rpg; tpy;iyfSlNd ghj;jpuj;jpw; gj;jpug;gLj;j 
Ntz;Lk;. 
 
gpukhzk;: 
  nea; khj;jpuk;  1 ¼  - 2 tuhfndil fhiy khiy 
 
jPUk; Neha;fs;: 
  fzNuhfq;fs;> fzNuhfj;jhYz;lhFk; mul;ly; Gul;ly;> 
Njh\q;fs;> twl;Nrhif ,Uky;> fhrNuhfk;> fgNuhfk;> Fj;jpUky;> 
thAf;fs; Mfpait jPUk;. 
 
MAl;fhyk;: 
  6 khj fhyk; 
 “tps; kzg;ghF nea; ,urhad 
 kpsF ehy; NkT kW jpq;fs; 
     - Fzghlk; jhJ rPt tFg;G 
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fizf; fpUjk; (KANAI KIRUTHAM) 
 
 
 
INGREDIENTS OF KANAI KIRUTHAM 
 
J}Jtis (Solanum trilobatum) 
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rpWfPiu NtH (Amaranthus tricolor) 
 
 
 
jz;zPHtpl;lhd; fpoq;F (Asparagus racemosus) 
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mjpkJuk; (Glycyrrhiza glabra) 
 
 
  
     <Us;sp (Allium cepa)                gR nea; (Cows ghee) 
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PHARMACOLOGICAL ACTION OF INGREDIENTS 
1. J}Jtis 
NtW ngaH   :  J}Jtis> msHf;fk;> tpq;fty;yp 
Bot. Name  - Solanum trilobatum 
Family   - Solanaceae 
gad;gLk; cWg;G - ,iy> G+> fha; 
 Rit   - rpW ifg;G> fhHg;G 
 jd;ik   - ntg;gk; 
 gphpT   - fhHg;G 
 nra;if:  
 ntg;gKz;lhf;fp - Stimulant 
 Nfhioafw;wp  - Expectorant 
 cukhf;fp  - Tonic 
 
Fzk;: 
 
 NtH: 
   ‘thj gpj;jf gj;ijA khw;WNtH”  (mfj;jpah; Fzthflk;) 
 ,iy: 
   ‘fhJke;jk; fhnjOr;rp fhre; jpdTkjk;  
     XJke;j Kj;Njhlk; cl;#iy”  (mfj;jpah; Fzthflk;) 
 G+: 
   ‘IaKld; gpj;jk; mfYk; mNuhrfk; Nghk;”  
(mfj;jpah; Fzthflk;) 
 gok;: 
   ‘fgf;fl;L Nfhio fjpj;jjphp Njhlk; 
     FGf;nfd; nwOk;GePHf; Nfhit”   
(mfj;jpah; Fzthflk;) 
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,Uky;> ,iug;G> Iaj;jhYz;lhFk; fhJke;jk;> fhnjOr;rp> ,Uky;> 
eikr;ry;> ngUtapW> ke;jk;> khHGr;rsp> ePNuw;wk; ,it ePq;Fk;. 
 
Phytochemicals  and Therapeutic uses:  
 
Beta solamarine is a major glycol alkaloid. It also contains solasodine a        
valuable steroid, solasonine, Flavanoids, Tanins, Saponins and Phytosterols. 
Anti-inflammatory, antioxidant, Immunomodulatory, Anti-asthmatic, 
Hepatoprotective effects. 
 
Recent Research study on Solanum trilobatum in the inhibition of 
Mast cell degranulation: (PMJ-Pharmacognosy research-V2(1) Jan-
Feb2010) 
 
The efficacy of Solanum trilobatum in the inhibition of Mast cell 
degranulation was reconfirmed by Dust inhalation Study. In the Solanum 
trilobatum treated animals, the release of histamine was very low in response to 
dust exposure.   
            
2. rpWfPiu NtH: 
NtW ngaH  :  rpy;yp  
Bot. Name - Amaranthus tricolor 
 Family - Amaranthaceae  
Rit  - ,dpg;G 
jd;ik - rPjk; 
gphpT  - ,dpg;G 
 nra;if: 
  rpWePHg;ngUf;fp  - Diuretic 
  FspHr;rpAz;lhf;fp  -  Refrigerant 
  kykpsf;fp   - Laxative 
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Fzk;: 
   fz;Gifr;r Nej;jpuNeha; fhrk; glyk; 
    Gz;fphpr;r uQ;Nrhig nghq;Fgpj;j – kz;guT 
   jhtutplq;fSk; Nghk; jhohj; jpUTKz;lhk; 
    $WrpW fPiujidf; nfhs;.  
   fz;Gifr;ry;> fz;fhrk;> moy;Neha;fs;> jhtutplk;> ePq;Fk;.  
 
Phytochemicals and Therapeutic uses: 
It contains Amaranthine, Isoamaranthine, Isobetadine.It is rich in proteins 
especially aminoacid and Lysine. It also contains Iron, Phosphorous, 
Carbohydrates.(Journal of Biotechnology vol2 May 2012). 
 
Recent Research Studies on Immunomodulatory effect of 
Amaranthus.(Pubmed foodsciAp77) 
 
It stimulates the immune system and has been reported to possess anti-
allergic and antioxidant activities. 
 
3. jz;zPHtpl;lhd; fpoq;F 
NtW ngaH   :  rjhNthp> thpthp> cjf%yk;.  
            rpf;Fit> gwiz> ehuhazp 
Bot. Name  - Asparagus racemosus 
Family   - Liliaceae  
gad;gLk; cWg;G - ,iy> fpoq;F 
Rit   - ,dpg;G 
jd;ik   - jl;gk; 
gphpT   - ,dpg;G 
nra;if :  
clYukhf;fp  - Nutritive 
cs;soyhw;wp  - Demulcent 
,rptfw;wp  - Antispasmodic 
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  ‘ePhpopitg; Nghf;Fk; neLehl;R uj;ijnayhk; 
    CiutpLj; NjhlT iuf;Fq;fhz; - ehhpaNu! M 
   ntz;zPHnga; NrhkNeha; ntl;il ady;jzpf;Fe; 
    jz;zPHtpl; lhd;fpoq;F jhd;”.   
(mfj;jpah; Fzthflk;) 
 
  ehl;gl;l Ruk;> vYk;GUf;fp Neha;> cl;#L ,it ePq;Fk;. 
 
Phytochemicals and Therapeutic uses: 
          Sarsapogenin is an important glycoside of Pharmacological value. It is 
highly mucilaginous, tonic, nutritive, diuretic, antispasmodic, antiseptic, 
antitussive, expectorant and also used in fever and constipation. The Plant 
has significant beneficial effects in dyspepsia, acid-pepsin disease.  (Reviews 
on Indian medicinal plantsVol3, 2004). 
 
Recent  research  study on Asparagus racemosus on immunomodulator 
activity.(pubmed j.ethnopharmacd2009,jan121) 
 
     Sarsapogenin glycoside is an immunoside. . It is an immunomodulator on 
systemic Th1/Th2 Immunity and can be used as immunoadjuvant potential. 
  
4. <Us;sp 
 
NtW ngaH  :  ntq;fhak;> cs;sp> epr;rpak;> gyhz;L>      
                 Rf;fpue;jk; 
Bot. Name  - Allium cepa 
Family  - Liliaceae  
gad;gLk; cWg;G - G+> jhs;> fpoq;F> tpij 
Rit   - ifg;G> 
jd;ik  - ntg;gk; 
gphpT   - fhHg;G 
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nra;if: 
ntg;gKz;lhf;fp  - Stimulant 
 rpWePHg;ngUf;fp  - Diuretic 
 Nfhioafw;wp  - Expectorant 
 cs;soyhw;wp  - Demulcent 
 
  ‘ntg;g% yq;fpue;jp tPWuj;j gpj;jKld;  
    nrg;Geh mf;fue;jP uhj;jhfk; - ntg;Gf; 
   fLg;gWke; jQ;re;ep fhrk;tapw; Wg;gy; 
    jbg;gWk; ntq;fhaj;jhy;.” (mfj;jpah; Fzthflk;) 
 
cly;ntg;gk;> mf;fuk;> ePHNtl;if> Kg;gpzp> ,Uky;> tapw;Wg;gprk; 
,it ePq;Fk;.  
 
Phytochemicals and Therapeutic uses: 
 
    Quercetin, Bioflavanoid, Anthocyanin, Myricetin. It has nutritional value 
as it contains ferulic acids, vitamin B&C, carbohydrates. It has stimulant, 
diuretic, anti-spasmodic, antimicrobial action. It is used as expectorant in 
Pediatric cough and also used in fever, flatulence, Indigestion and eczema.  
Recent research studies in Alium cepa (Pub med Eurj pharmacol 1984 
dec 15)  
    Benzyl isothiocyanates one of the component of Alium cepa has Asthma 
protective effect. Alkylsulfithioic acid esters inhibit histamine release, 
leukotriene and Thromboxane biosynthesis in vitro and counter act PAF 
allergen induced bronchial obstruction in vitro.(Pubmed-biochempharmacol 
1988Dec1) 
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mjpkJuk;:- 
NtW ngaH   :  mjpq;fk;> ml;b> kJ}fk;> Fd;wpNtH  
Bot. Name  - Glycyrrhiza glabra 
Family   - Fabaceae  
gad;gLk; cWg;G - NtH 
Rit   - ,dpg;G 
jd;ik   - rPjk; 
gphpT   - ,dpg;G 
 
nra;if: 
twl;rpafw;wp  - Emolient 
cs;soyhw;wp  - Demulcent 
Nfhioafw;wp  - Expectorant 
cukhf;fp  - Tonic 
 
‘jpj;jpf;F kjpkJuf; Fzj;ijnaLj;J iuf;fpy; 
rpukaf;fQ; Rujhfe; jphpNjhlq;fs; gpj;jQ;rj; jpf;FkpJ ...” 
‘Gife;njLf;FQ; Nrl;Lkj;ijg; gpj;jNuhfj;ij 
mj;jpg;gw; wpdNkfe; jd;idth jj;jpid aWj;jpLk; ...” 
 
Iaj;jhYz;lhd Nfhioia ,sfr; nra;Ak; 
jPf;Fw;wj;jpd; td;ikiaj; jhor; nra;Ak.; 
 
Phytochemicals and Therapeutic uses: 
   Beta Glycyrrhetinic acid, Liquiritigenine, Liquiritine, Disodium 
glycyrohetinic acid,Glycyrin.. 
 
Recent research study on evaluation of anti-asthmatic activity of 
Glcyrrhiza glabra:(Biosciences-biotechnology research Asia2009Vol2) 
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Purified Saponin fraction of extract of Glycyrrhiza glabra is effective as 
antiasthmatic agent in triple antigen sensitized albino rats and mast cell 
inhibition. 
 
Beta Glycyrrhetenic acid has antibacterial activity. Glycyrrhizin has anti 
inflammatory activity and suppresses both eicosanoids and 
Leukotriens.(Microbiolimmunol2003 Jan-june). 
 
5. gR nea;: 
 ‘jhfko iyRl;rk; the;jpgpj;jk; thAgpu 
   Nkfk; tapw;nwhhpT tpf;fyoy; - khfhrq; 
  Fd;kk; twl;rp Flw;Gul;l y];jpRl;lQ; 
   nrhd;%yk; Nghf;F epiwj; Jg;G” 
 
gRtpd; nea;ahdJ jhfk;> moiyg;gpzp> mjpRl;f Neha;> the;jp> 
gpj;jhjpf;fk;> twl;rp  ,it ePf;Fk;. 
 
It is an excellent pacifier of aggravated vatha and Pitha doshas in the 
body. It stimulates the gastric fire “agni” without aggravating pitham, by 
increasing the secretion of biliary lipids and gastric acid secretion. It is Rich in 
antioxidants and nourishes and strengthens the immune system.  
 
Medicated Ghee contains the fat soluble medicinal principles of the drugs 
used in the preparation. The basic principle of preparation is the transfer of fat 
soluble active principles of the drugs to Ghee. 
 
Its high concentration of butanoic acid has antibacterial activity. 
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One table spoon of ghee yields 112 calories. 
 
Some important constituents of Ghee are: 
     Total fat     - 12.73g 
     Saturated fat                 -   7.926g 
     Polyunsaturated Fat     -  0.473 
     Monounsaturated Fat    -  3.678g 
     Cholesterol                    -  33mg 
     Potassium                        -  1mg 
     Protein                                 -  0.04g 
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                                                             ANNEXURES 
ANNEXURE II 
PHYTOCHEMICAL ANALYSIS 
GAS CHROMATOGRAPHY – MASS SPECTROMETRY 
Introduction: 
  Mass spectrometry has become one of the most important 
analytical tools of today. The use of it has spread to a large number of areas 
such as molecular physics, chemistry, biology and medicine.  One of the 
important analytical tools placed in SAIF, IITM is GC-MS. It is a 
combination of Agilent technologies (Gas chromatographic system) and Jeol 
GC mateII (Mass spectrometry).  
 
JEOL GCMATE II GC-MASS SPECTROMETER 
 
Principle: 
                    As Chromatographic principle implies, Gas liquid Chromatography 
too bases on “like dissolves like”. Depending on the polarity of stationary phase 
and eluting molecule, partitioning or retaining takes place due to the interaction 
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between them, so that resolution takes place in between two different 
molecules.  
Mass spectrometry is based on deflection of charged species in the presence of 
magnetic field, in different paths with respect to their molecular or atomic 
weights.  
 
Sample preparation:  
 
           Sample preparation can do by taking sample in a clean container and 
dissolving in suitable solvent. The solution then injected with the help of a 
micro syringe into injection port of GC system. In Mass spectrometry, through 2 
ways sample can be introduced viz. DI, and GC inlet. 
 
Procedure - High Resolution Mass Spectrometry  
 
 Setting the instrument for high resolution is accomplished by adjusting 
the widths of the ion source and collector slits (called the entrance and exit slits 
respectively). Under ideal conditions a maximum resolution of 5000 can be 
attained. 
 
        The main purpose of high resolution technique is to determine the precise 
mass of the ions. This can be achieved by using data system. The precise mass 
is determined by comparing the unknown mass of the sample peak with the 
known mass of a reference peak. The reference sample used here:  
Perfluorokerosene (PFK).  
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Block diagram of Gas chromatography- Mass 
Spectrometry 
 
 
 
 
 
 
 
Carrier gas 
 DI probe 
Injection port Column 
GC-MS 
Coupler 
Ionization         
   chamber Analyzer  Detector 
 EI/CI source 
Vacuum    
 system 
Sample 
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PRELIMINARY GC-MS ANALYSIS OF KANAI 
KIRUTHAM 
 
 
 
     INTERPRETATION  
 
S.no Phytoconstituents Rt Aqueous 
1 Alkaloids 11.0 + 
2 Saponins 9.42 + 
3 Glycosides 10.37 + 
4 Carbohydrates 11.53 + 
5 Triterpenoids 10.48 + 
 
 + = Present, − = Absent. 
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ANNEXURE III 
 
BIO-CHEMICAL ANALYSIS OF KANAI KIRUTHAM 
 
Preparation of the extract 
 5gms of the drug in powdered form without ghee was weighed accurately 
and placed in a 250ml clean beaker. Then 50ml of distilled water is added and 
dissolved well. Then it is boiled well for about 10 minutes. It is cooled and 
filtered in a 100ml volumetric flask and then it is made up to 100ml with 
distilled water. This fluid is taken for analysis. 
QUALITATIVE ANALYSIS 
S.NO. EXPERIMENT OBSERVATION INFERENCE 
1.  TEST FOR CALCIUM 
2ml of the above prepared extract is taken in 
a clean test tube.  To this add 2ml of 4%  
Ammonium oxalate solution 
No white precipitate is 
formed 
Indicates the absence 
of calcium 
2. TEST FOR SULPHATE: 
2ml of the extract is added to 5% barium 
chloride solution. 
No white precipitate is 
formed 
Absence of sulphate 
3. TEST FOR CHLORIDE 
The extract is treated with silver nitrate 
solution 
A white precipitate is 
formed 
Indicates the  
Presence of chloride 
4. TEST FOR CARBONATE 
The substance is treated with concentrated 
Hcl. 
No brisk effervescence 
is formed 
Absence of 
carbonate 
5. TEST FOR STARCH 
The extract is added with weak iodine 
solution. 
No blue colour is 
formed 
Absence of starch 
 
6 TEST FOR FERRIC IRON 
The extract is acidified with Glacial acetic 
acid and potassium ferro cyanide. 
No blue colour is 
formed 
Absence of ferric 
iron 
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7. TEST OF IRON FERROUS 
The extract is treated with concentrated 
Nitric acid and ammonium thio cynaate 
solution 
Blood red colour is 
formed 
Indicates the 
presence of ferrous 
iron 
8. TEST FOR PHOSPHATE 
The extract is treated with ammonium 
Molybdate and concentrated nitric acid. 
No yellow precipitate is 
formed 
Absence of 
phosphate 
9. TEST FOR ALBUMIN 
The extract is treated with Esbach’s reagent 
No yellow precipitate is 
formed 
Absence of albumin 
10. TEST FOR TANNIC ACID 
The extract is treated with ferric choloride. 
No blue black 
precipitate is formed 
Absence of tannic 
acid 
11. TEST FOR UNSATURATION 
Potassium permanganate solution is added 
to the extract 
It gets decolourised 
Indicates the 
presence of 
unsaturated 
compound 
12. TEST FOR THE REDUCING SUGAR 
5ml of Benedict’s qualitative solution is 
taken in a test tube and allowed to boil for 2 
mts and  8-10 drops of the extract is added 
and again boiled  for 2 mts. 
 Colour change occurs 
Indicates the 
Presence of reducing 
sugar 
13. TEST FOR AMINO ACID 
One or two drops of the extract is placed on 
a filter paper and dried well. After drying, 
1% Ninnydrin is sprayed over the same and 
dried well. 
No violet colour is 
formed 
Absence of amino 
acid 
14. TEST FOR ZINC: 
The extract is treated with potassium Ferro 
cyanide. 
No white precipitate is 
formed 
Absence of zinc 
 
Inference: 
 The above analysis indicates the presence of ferrous iron, chloride, 
unsaturated compound and reducing sugar. 
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ANNEXURE IV 
PHARMACOLOGICAL STUDIES 
ACUTE ANTI - INFLAMMATORY STUDY ON KANAI KIRUTHAM BY 
HIND-PAW METHOD IN ALBINO RATS 
Aim: 
 To study the acute anti-inflammatory effect of Kanai kirutham. 
 
Preparation of the test drug: 
  A dose of 2 ml of test drug was administered along with control vechicle 
(distilled water) 60 minutes prior to the injection of carrageenan. 
 
Procedure: 
 Six healthy albino rats weighing 100-150 gm were taken and divided into 
three groups, each consisting of 2 rats. 
 First group was kept as control by giving distilled water of 2 ml /100 gm 
of body weight.  The second group was given Ibuprofen at dose of 20mg/100 
gm of body weight.  The third group received the test drug 200 ml Kanai 
kirutham. 
 Before administration of test drug, the hind-paw volumes of all rats were 
measured.  This was done by dipping the hind-paw (up to tibio-tarsal function) 
in to a mercury plethysmography.  While dipping the hind-paw, by pulling the 
syringe piston, the level of mercury in the centre small tube was made to 
coincide with red marking and reading was noted from the plethysmograph. 
 Soon after the measurement, the drugs were administered orally.  One 
hour later, a subcutaneous injection of 0.1 ml of 1% (w/v) carrageenan in water 
was made into plantar surface of both hind-paw of each rat.  Three hours after 
carrageenan injection, the hind – paw volumes were measured once again.  The 
differences between the initial and final volumes were calculated and compared. 
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 The method is more suitable for studying the anti-inflammatory activity 
in acute inflammation.  The values are given in the table: 
 
Effect of Kanai kirutham 
Groups Drug 
Dose/100gm 
body 
weight 
Initial 
Reading 
average 
Final 
Reading 
average 
Mean 
difference 
In
fl
a
m
m
a
ti
o
n
 %
 
In
h
ib
it
io
n
 %
 
Remarks 
Control Water 2ml 0.55 1.4 0.85 100 - 
 
Significant 
Standard Ibuprofen 20mg 0.55 0.75 0.20 23.5 76.5 
Test 
drug 
Kanai 
kirutham 
2ml 0.7 1.0 0.3 35.2 64.8 
 
 
Inference:  
  Kanai kirutham has Significant Acute Anti-inflammatory action.  
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ANTI-PYRETIC STUDY OF KANAI KIRUTHAM 
(By yeast induced method) 
Aim: 
 To study the anti pyretic activity of Kanai kirutham. 
 
Procedure: 
 Group of six albino rats were selected and divided equally into 3 groups.  
All the rats were made hyperthermia by subcutaneous injection of 12% 
suspension of yeast at a dose of 1 ml/100 gm of body weight. 
 
 10 hours later one group of animals received only distilled water at a dose 
of 2ml. Second group received standard drug paracetamol 20 mg/ml and the 
third group received the test drug by gastric tube at a dose of 250 mg/ml.  
  
Then mean rectal temperature for the 3 groups were recorded at                   
0 hour. 1 ½ hours, 3 hours and 4 ½ hours after the drug administration.  The 
different between the mean temperature of the control group and that of the 
other groups was measured. 
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TABULATION OF RESULTS OBTAINED 
 
Sl.
No 
Name of the 
drugs/ 
groups 
Dose/ 
100gm 
body 
weight 
Initial 
temperature 
in centigrade 
After drug administration Remarks 
1 ½ hr 
Average 
3 hr 
Average 
4 ½  hr 
Average 
Significant 
1 
Control 
(water) 
2 ml 
37.5 
37.5 
38.0 
38.0 
38.5 
38.5 
38.5 
38.5 
2 
Standard 
Paracetamol 
20mg 
37.0 
37.0 
36.0 
36.0 
 
35.0 
35.0 
 
34.0 
34.0 
3. 
Kanai 
kirutham 
2 ml 
37.0 
37.0 
36.5 
36.0 
36.0 
36.0 
35.5 
35.5 
 
Inference:  
  Kanai kirutham has significant antipyretic action. 
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ANTI – HISTAMINE EFFECT OF KANAI KIRUTHAM 
ON ISOLATED GUINEA PIG ILEUM 
Aim: 
 To find out the Anti-histamine effect of Kanai kirutham on isolated 
guinea pig ileum. 
 
Preparation of the test drug: 
 1 gm of Kanai kirutham was dissolved in 5ml of honey and 5ml of 
distilled water.  The filtrate was used for the experiment. 
 
Solutions required: 
  
 Test drug- Kanai kirutham (2ml) 
 
Nutrient solution: 
 Tyrode – 1 to 2 litres 
 
Tissue used: 
 Isolated guinea pig ileum 
 
Apparatus required: 
 Student’s organ bath 
 Sherrington rotating drum 
 
Procedure: 
 An overnight fasted guinea pig weighing about 400 Gms was sacrificed 
by a blow on the head and by carotid bleeding.  The abdomen was suddenly 
opened and ileo caecal junction was found out.  A small piece of ileal portion 
was cut and removed and placed in a dish, containing warm aerated tyrode 
solution. 
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 The lumen of the ileum was gently rinsed out by pushing tyrode solution 
into it, 3 m length segment was cut from this part of ileum and was tied with 
thread on both ends without closing the lumen and the tissue was mounted in 
the organ bath containing tyrode solution maintained at 37C and bubbled with 
air by an oxygen tube. 
 
 First the drum was allowed to run for 1 minute from the baseline.  Drugs 
were give to study the inhibiting effect of histamine 0.2ml of histamine was 
added and allowed to run the drum for 30 seconds.  Thus the tissue was 
standardized and then the drum was stopped and the histamine was washed out. 
 
 Again the tyrode solution was added to the organ bath till the lever comes 
to the baseline.  The drum was allowed to run for 1 minute. 
 
 To the organ bath 1 ml of test drug was added, waited for 1 minute then 
0.2ml of histamine was added and the drum was allowed to run for 30 seconds.  
The response was recorded. 
 
Inference: 
  From the graph it is inferred that the test drug antagonize the effect of 
Histamine when added together. So the drug Kanai kirutham has got 
significant Anti – histamine activity. 
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ANTI-SPASMODIC EFFECT OF   KANAI KIRUTHAM 
ON ISOLATED RABBIT ILEUM. 
Aim: 
     To find out the antispasmodic effect of Kanai kirutham on isolated rabbit 
ileum. 
 
Solutions required: 
    Acetylcholine -10gm/ml 
    Atropine          -10mg/ml 
    Test drug         -Kanai kirutham 5ml 
Nutrient solution: 
Tyrode               -1-2 litres. 
Tissue used:  
      Rabbit ileum 
Apparatus required: 
      Student’s organ bath. 
     Sherrington rotating drum. 
 
Procedure: 
      A Rabbit was starved for 48 hours and was allowed water adlibtum. It was 
sacrificed by a blow on the head and by carotid bleeding. The abdomen was 
quickly opened and the ileocaecal junction was found out. A small piece of ileal 
portion was taken out, removed and placed in a dish containing warm aerated 
Tyrode solution. The lumen of the ileum was gently rinsed out by pushing 
Tyrode solution into it, 3cm length segment was cut from the spot of ileum and 
was tied with thread on both ends without closing the lumen and the tissue was 
mounted in the organ bath containing Tyrode solution maintained at 37 degree 
Celsius and bubbled with air by the oxygen tube. 
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     First the drum was allowed to run for 1 minute from the baseline. Drugs 
were given to study the inhibiting effect of Acetyl choline. 0.2ml of 
Acetylcholine was added and allowed to run the drum for 30 seconds. Thus the 
tissue was standardised and then the drum was stopped and the Acetylcholine 
was washed out. 
 
   Again the Tyrode solution was added to the organ bath till the lever 
comes to the baseline. The drum was allowed to run for 1 minute. To the organ 
bath 1ml of test drug was added and waited for 1 minute then Acetylcholine was 
added and the drum was allowed to run for 30 seconds. The response was 
recorded. Then the drum was stopped and the Acetylcholine solution and test 
drug solution were washed out. Then the above experiment was done for 0.2ml 
dose of Acetylcholine. The drum was allowed to run for 30 seconds. The 
responses were recorded. 
 
    Then 0.2ml of Atropine and 0.2ml of Acetylcholine was added and the 
drum was allowed to run for 30 seconds. There is no elevation in the graph and 
it seems to be at baseline. Then the tracing was labelled and fixed. 
 
Inference: 
    From the graph it is inferred that the test drug moderately antagonise the 
effect of Acetylcholine when added together. So the drug Moderate 
Antispasmodic activity.  
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ANNEXURE V 
ANTIMICROBIAL STUDIES 
Aim 
 To study the Anti-microbial action of “Kanai kirutham” by “Paper disc 
agar diffusion method” ( Kirby – bauyer method). 
 
Medium 
Muller Hinton agar. 
Components of medium 
Beef extract   - 300gms/lit 
Agar    - 17 gms/lit 
Starch   - 1.5 gms/lit 
Casein Hydrolysate - 17.5 gms/lit 
Distilled water  - 1000 ml 
PH    - 7.6 
Procedure 
 Preparation of inoculum 
 The given micro organism is inoculated in 1 ml of peptone water under 
sterile condition.  The inoculum is incubated at 37C for 2 hours then the 
turbidity of the inoculum is adjusted to 0.5 µc Farland turbidity standard.  The 
inoculum was poured in a Muller Hinton agar plate and uniformly spreaded 
over the plate.  The excess inoculum was discarded. 
Disc preparation 
 The known quantity of the given chemical compound is impregnated in a 
6mm diameter filter paper disc and applied over the inoculum.  Then the Muller 
Hinton agar plate is incubated at 37C for overnight.  The zone of clearance is 
measured with a scale and the sensitivity of the organism to the given trial drug 
is assessed.  The diameter of zone of inhibition was observed and recorded. 
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ANTI BACTERIAL STUDY 
 
 
Streptococcus pneumonia 
 
 
  
Staphylococcus aureus 
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GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL  
PALAYAM KOTTAI 
Branch -IV KUZHANTHAI MARUTHUVAM 
SCREENING PROFORMA 
QUESTIONNAIRE FOR DIAGNOSING CHILDHOOD ASTHMA 
Name: ______________________________________________________ 
Address:_____________________________________________________ 
________________________________Tel. No. _______________________ 
Age _____________________ Sex ________________________________  
Father’s Occupation______________________________________________ 
Mother’s Occupation______________________________________________ 
Presenting Complaints 
Age at onset of symptom 
COUGH 
Duration  ___________________________________________ 
Expectoration   Mucoid    Purulent M Mucopurulent  Nil 
Predominantly   Day  Night  No diurnal variation  
Aggravating factors ________________________________________________ 
Chest pain __________________          Yes   No   
WHEEZING 
Duration   _____________________________________ 
No.of previous episodes___________________________________ 
Predominantly during  Day  Night  No diurnal variation  
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Aggravating factors ________________________________________________ 
HISTORY OF GER 
H/o Regurgitation    Yes   No 
Epigastric pain    Yes   No  
Night – time awakening   Yes   No 
Swallowing difficulty   Yes   No 
OTHER SYMPTOMS 
Frequent nose block   Yes   No  
Frequent running nose   Yes   No  
Sneezing with watery discharge  Yes   No 
Itching in throat     Yes   No 
Itching in ears    Yes   No 
Excess mucus production  Yes   No 
Skin rash     Yes   No 
Urticaria     Yes   No 
EFFECT OF  
Dust  
Vehicular smoke   Exacerbation  No effect 
Cooking fuel smoke  Exacerbation  No effect 
Cigarette/beedi smoke  Exacerbation  No effect 
Dampness    Exacerbation  No effect 
Weeds, Grass   Exacerbation  No effect  
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Harvesting or wheat threshing  Exacerbation  No effect 
Cold wind    Exacerbation  No effect  
Pet animals    Exacerbation  No effect 
Eating egg/egg products  Exacerbation  No effect 
Foods     Exacerbation  No effect  
Use of cosmetics/shampoos Exacerbation  No effect 
Use of paints/Chemicals   Exacerbation  No effect  
Consumption of drugs  Exacerbation  No effect 
Exertion and exercise  Exacerbation  No effect  
Emotional upsets   Exacerbation  No effect 
SYMPTOMS RELIEVED BY 
Spontaneously    Yes   No 
Bronchodilators    Yes   No  
Inhaled steroids    Yes   No 
Others, specify    Yes   No 
SEASONAL VARIATION 
Is there seasonal variation of symptoms?     Yes   No 
FAMILY HISTORY 
No.of family members_____________________________ 
No.of siblings   Older ______________  Young ___________ 
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Presence of overcrowding  Yes   No 
Family h/o similar complaints   Yes   No 
Family h/o atopic dermatitis  Yes   No 
Family h/o food allergy   Yes   No 
Family h/o hay fever/rhinitis  Yes   No 
Family h/o urticaria    Yes   No 
ENVIRONMENTAL HISTORY 
Presence of dampness   Yes   No 
Use of carpets    Yes   No 
Use of soft toys    Yes   No 
Presence of pets/household     
Animals  Yes No 
Use of kerosene/wood/   
Coal fuel      Yes   No 
Presence of cockroaches   Yes   No 
Presence of dusty        
Bookshelves    Yes   No 
TREATMENT HISTORY 
H/o previous hospitalizations   Yes   No 
No.of previous hospitralizations ________________________________ 
Use of nebulization    Yes   No 
Use of drugs    Yes   No 
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Use of inhaler     Yes   No 
Examination 
Wt_________________(Kg)   Ht __________________(kg) 
       HR__________________ 
RR__________________   BP___________________ 
Pallor      Yes   No 
Cyanosis     Yes   No 
Clubbing     Yes   No 
.Lymphadenopathy   Yes   No 
Skeletal & chest wall    
Abnormalities    Yes   No 
Ear discharge    Yes   No 
Throat congestion    Yes   No 
Tonsillar hypertrophy   Yes   No 
Skin lesions     Yes   No 
Eye signs of allergic rhinitis  Yes   No 
 
CVS 
Abdomen 
CNS  
DIAGNOSIS 
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GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
  PALAYAMKOTTAI  
Branch -IV KUZHANTHAI MARUTHUVAM  
PROFORMA OF CASE SHEET FOR SUZHI KANAM 
 
IP. No  :    Nationality  : 
Name   :    Religion  : 
Age          :    Date of Admission : 
Sex        :    Date of Discharge : 
Address    :    Diagnosis  : 
Informant  :    Medical Officer : 
 
1. Complaints and duration   :    
2. History of present illness   :    
3. History of Past illness           :    
4. Antenatal history   :     
5. Birth history    :     
6. Neonatal history   :    
7. Developmental  history  : 
8. Nutritional  history   : 
9. Immunization history                    : 
10. Family history            : 
11. Socio economic status  : 
 
General examination 
 1. Appearance and posture : 
 2. Nutritional status                   : 
3. Anaemia    : 
4. Cyanosis    : 
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5. Clubbing    : 
6. Jaundice    : 
7. Lymphadenopathy  : 
8. Abdominal distension  : 
9. Pedal oedema   : 
    
Vital Signs 
1. Temperature  : 
2. Pulse rate  : 
3. Respiratory rate : 
4. Heart rate  : 
           5.  Blood pressure    : 
 
Anthropometry    
                a.    Height  : 
 b.   Weight  : 
                c.    Chest circumference: 
 
 SIDDHA ASPECTS  
  Nilam 
1. Kurinji   : 
2. Mullai   : 
3. Marutham  : 
4. Neithal   : 
5. Paalai    : 
 
Paruvakaalam 
1. Kaar   : 
2. Koothir   : 
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3. Munpani    : 
4. Pinpani   : 
5. Elavenil   : 
6. Muthuvenil   : 
 
Poripulangal   
1. Mei   : 
2. Vai   : 
3. Kan   : 
4. Mooku   : 
5. Sevi   : 
 
Kanmenthiriyam  
1. Kai   :  
2. Kaal   : 
3. Vaai   : 
4. Eruvai    : 
5. Karuvai    : 
 
Uyir thathukkal  
Vadham 
1. Praanan   : 
2. Abaanan   : 
3. Viyaanan  : 
4. Uthaanan  : 
5. Samaanan  : 
6. Naagan   : 
7. Koorman   : 
8. Kirukaran  : 
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9. Devathathan  : 
10. Dhananjeyan  : 
 
Pitham 
1. Analpitham  : 
2. Ranjagam  : 
3. Saadhagam  : 
4. Praasagam  : 
5. Aalosagam  : 
 
Kabam 
1. Avalambagam : 
2. Kiletham  : 
3. Pothagam  : 
4. Tharpagam  : 
5. Santhigam  : 
 
Udar kattugal 
1. Saaram  : 
2. Senneer  : 
3. Oonn   : 
4. Kozhuppu  : 
5. Enbu   : 
6. Moolai  : 
7. Sukkilam / Suronitham:    
 
Envagai thervugal 
1. Naadi   : 
2. Sparisam  : 
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3. Naa   : 
4. Niram           : 
5. Mozhi  : 
6. Vizhi            : 
7. Malam: 
8. Moothiram   : 
 
MODERN ASPECTS  
Respiratory System  
      1. Inspection  : 
2. Palpation  : 
3. Percussion  : 
4. Auscultation : 
 
Examination of other system 
Cardiovascular system  : 
Gastro intestinal system : 
Central nervous system : 
Excretory system  :  
 
Laboratory investigations  
Blood 
TC    : 
DC    : 
ESR   : 
1
/2 hr  : 
1 hr  : 
Hb%  : 
 
 145 
Urine 
  Albumin   : 
  Sugar   : 
Deposits  : 
Stools 
Ova   :  
Cyst   : 
 
Other Investigations 
X-ray- chest PA view:  
Mantoux test      : 
Peak Expiratory Flow: 
 
Investigation - Siddha aspect 
 1. Neerkuri 
Niram  : 
Edai   : 
     Manam  :   
     Nurai   : 
Enjal   : 
2. Neikuri 
3. Daily progress 
Date Symptoms Medicine 
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GOVT. SIDDHA MEDICAL COLLEGE AND HOSPITAL,  
POST GRADUATE DEPARTMENT. PALAYAMKOTTAI.  
Branch -IV KUZHANTHAI MARUTHUVAM 
ADMISSION - DISCHARGE CASE SHEET 
Name of the Medical Unit: 
IP. NO   : 
Bed no   : 
Ward    : 
Name   : 
Age    : 
Sex   : 
Permanent address: 
Temporary address: 
Informant   : 
 
S.No 
CLINICAL FEATURES               
(Signs and Symptoms) 
During 
Admission 
During 
Discharge 
1    
2    
3    
4    
5    
6    
7    
8    
9    
10    
 
Occupation   : 
Income   : 
Nationality   : 
Religion  : 
Date of Admission: 
Date of discharge : 
Diagnosis   : 
Results  : 
Medical officer : 
 
 147 
BIBLIOGRAPHY 
 
1. Foe;ij kUj;Jtk; (ghythflk;) - f.r.KUNfr KjypahH>                
        kU.nghd;FUrpNuhd;kzp. 
2. Fk;gKdp ghythflk;-  A.T.S.V.Siddha  Medical College 
3. kjiyNeha; njhFjp – II  A.T.S.V.Siddha  Medical College 
4. guuhrNrfuk;> ghyNuhf epjhdk; - I. nghd;idahgps;is 
5. ruNge;jpu itj;jpa Kiwfs; -fh;g;gpzp ghyNuhf rpfpr;ir  
- thRNjt rh];j;jphp 
6. etuj;jpd rpe;jhkzp 800  - jpUts;St ehadhH 
7. Mtpaspf;Fk; mKjKiw RUf;fk; - S.P. ,uhkre;jpud; 
8. Mj;k uhl;rhkph;jk; vDk; itj;jpa rhu rq;fpufk; - fe;jrhkpgps;is 
9. [Ptul;rhkph;jk; - MWKfk; gps;is 
10. gps;isg; gpzp kUj;Jtk;  - Dr. m.Re;jh;uh[d; 
11. mgpjhd rpe;jhkzp - rpq;fhu NtY KjypahH 
12. rpj;j kUj;Jthq;f RUf;fk; - Dr.f.R. cj;jkuhad; 
13. rpj;j kUj;Jt Neha;ehly; Neha; Kjy;ehly; jpul;L - Dr. k.rz;KfNtY  
14. jkpo; - Mq;fpyk; mfuhjp - T.V. rhk;g rptk;gps;is 
15.  jkpo; nkhop mfuhjp – eh. fjph;Nty; gps;is 
16. Fzghlk; -%ypif tFg;G- f.r .KUNfr KjypahH 
17. Fzghlk; - jhJ rPt tFg;G Dr.,uh.jpahfuh[d; 
18. kUj;Jt jhtutpay;- v];. NrhkRe;juk; 
19. Njud; Nrfug;gh 
20. gps;isg;gpzp thflk; 
21. jd;te;jphp itj;jpak; 
22. mNahj;jpjhrh; ghythflk; 
23. rpj;;j kUj;Jt kzpfs; 
24. Njiuah; ntz;gh 
25. gjhHj;j Fz rpe;jhkzp 
26. jpU%yh; jpUke;jpuk;  
27. mfj;jpah; ty;yhjp ehb E}y;  
 148 
28. rjfehb 
29. jpUf;Fws; -jpUts;Sth; 
30. A+fp itj;jpa rpe;jhkzp 
31. gQ;r fhtpa epfz;L 
32. Wealth of India 
33. Indian Materia Medica – Nadkarni 
34. Medicinal Herbs with their formulation 
35. Indian Medicinal plants- Orient longman 
36. Nelson Text book of paediatrics – 18th Edition 
37. Achar’s Text book of paediatrics- 4th Edition   
38. GHAI Essential paediatrics – 7th edition 
39. Respiratory diseases-Crofton and doughlas  
40.  Textbook of medical microbiology – Ananthanarayanan 
41.  IAP Textbook of paediatrics. 
42. Quality standard of Indian Medicinal Plants ICMR 2003 
43. Bronchial Asthma, D.Behra 
 
Websites : 
 www.pubmed.com 
 www.openmed.nic.in 
 www.icmr.nic.in 
 www.ncbi.nlm.gov/pubmed 
 www.adc.bmj.com 
 
 
 
 
